UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2024
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
For the transition period from __________ to __________
 
Commission file number 0-53944
 
 
REGO PAYMENT ARCHITECTURES, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware   35-2327649

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

     
325 Sentry ParkwaySuite 200    
Blue BellPA   19422
(Address of Principal Executive Offices)   (Zip Code)
(267) 465-7530
(Registrant’s Telephone Number, Including Area Code)
 
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class Trading Symbol(s)

Name of Each Exchange on Which

Registered

None    

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   Accelerated filer  
Non-accelerated filer   Smaller reporting company  
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 136,148,105 shares of common stock outstanding at November 14, 2024.

 

 

 

 1 
 

 

TABLE OF CONTENTS

 

  Page
PART I - FINANCIAL INFORMATION  
   
Cautionary Note Regarding Forward-Looking Statements 3
ITEM 1.  Financial Statements 4
Condensed Consolidated Balance Sheets (Unaudited) 5
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) 6
Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) 7
Condensed Consolidated Statements of Cash Flows (Unaudited) 8
Notes to Condensed Consolidated Financial Statements (Unaudited) 9
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 23
ITEM 4. Controls and Procedures 23
   
PART II - OTHER INFORMATION  
     
ITEM 1. Legal Proceedings 23
ITEM 1A. Risk Factors 23
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
ITEM 3. Defaults Upon Senior Securities 23
ITEM 4. Mine Safety Disclosures 24
ITEM 5. Other Information 24
ITEM 6. Exhibits 24
SIGNATURES 25

 

 2 

 

PART I - FINANCIAL INFORMATION

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts included or incorporated by reference in this Quarterly Report on Form 10-Q, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objectives of management for future operations, are forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” “believes,” “contemplates,” “targets,” “could,” “would” or “should” or the negative thereof or any variation thereon or similar terminology or expressions. Management cautions readers not to place undue reliance on any of the Company’s forward-looking statements, which speak only as of the date made.

 

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, but are not limited to: our ability to raise additional capital, the absence of any material operating history or revenue, our ability to attract and retain qualified personnel, our ability to develop and introduce a new service and products to the market in a timely manner, market acceptance of our services and products, our limited experience in the industry, the ability to successfully develop licensing programs and generate business, rapid technological change in relevant markets, unexpected network interruptions or security breaches, changes in demand for current and future intellectual property rights, legislative, regulatory and competitive developments, intense competition with larger companies, general economic conditions, and other risks discussed in Part I – Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission (the “SEC”), and the Company’s other subsequent filings with the SEC.

 

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. The Company has no obligation to and does not undertake to update, revise, or correct any of these forward-looking statements after the date of this report.

 

 3 

 

ITEM 1. FINANCIAL STATEMENTS

Rego Payment Architectures, Inc.

CONTENTS

 

  PAGE
   
CONDENSED CONSOLIDATED BALANCE SHEETS 5
   
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS 6
   
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT 7
   
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 8
   
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 9 to 16

 

 4 

 

Rego Payment Architectures, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

  September 30, 2024   December 31, 2023 
ASSETS        
         
CURRENT ASSETS          
Cash and cash equivalents  $4,475,158   $6,256,634 
Prepaid expenses   50,000    18,322 
Deposits   341    341 
           
TOTAL CURRENT ASSETS   4,525,499    6,275,297 
           
OTHER ASSETS          
Patents and trademarks, net of accumulated amortization of $359,698 and $330,179   296,749    325,150 
    296,749    325,150 
           
TOTAL ASSETS  $4,822,248   $6,600,447 
           
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
           
CURRENT LIABILITIES          
Accounts payable and accrued expenses  $8,216,009   $7,785,443 
Accounts payable and accrued expenses - related parties   15,212    2,059 
Loans payable   42,600    42,600 
10% secured convertible notes payable - stockholders   3,036,237    3,316,357 
Notes payable - stockholders   595,000    595,000 
4% secured convertible notes payable - stockholders   14,981,250    14,981,250 
Preferred stock dividend liability   13,268,823    11,267,790 
           
TOTAL CURRENT LIABILITIES   40,155,131    37,990,499 
           
CONTINGENCIES   
 
    
 
 
           
STOCKHOLDERS' DEFICIT          
           
Preferred stock, $.0001 par value; 2,000,000 preferred shares authorized; 195,500 preferred shares Series A authorized; 98,350 shares issued and outstanding at September 30, 2024 and December 31, 2023   10    10 
          
Preferred stock, $.0001 par value; 2,000,000 preferred shares authorized; 347,222 preferred shares Series B authorized; 281,169 shares issued and outstanding at September 30, 2024 and 234,403 shares issued and outstanding at December 31, 2023   29    24 
          
Preferred stock, $.0001 par value; 2,000,000 preferred shares authorized; 300,000 preferred shares Series C authorized; 0 shares issued and outstanding at September 30, 2024 and December 31, 2023   
-
    
-
 
          
Common stock, $ .0001 par value; 230,000,000 shares authorized; 136,148,105 shares issued and outstanding at September 30, 2024 and 135,848,105 shares issued and outstanding at December 31, 2023   13,615    13,585 
           
Additional paid in capital   109,874,596    104,707,296 
           
Accumulated deficit   (145,221,133)   (136,110,967)
           
STOCKHOLDERS' DEFICIT   (35,332,883)   (31,390,052)
           
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT  $4,822,248   $6,600,447 

 

See the accompanying notes to the condensed consolidated financial statements.

 

 5 

 

Rego Payment Architectures, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited)

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
                 
NET REVENUE  $
-
   $
-
   $
-
   $
-
 
                     
OPERATING EXPENSES                    
Transaction expense   86,955    56,581    287,288    171,543 
Sales and marketing   116,605    468,115    526,065    1,475,458 
Product development   912,706    758,614    2,592,996    2,051,020 
General and administrative   810,411    905,699    2,961,321    9,534,184 
Total operating expenses   1,926,677    2,189,009    6,367,670    13,232,205 
                     
NET OPERATING LOSS   (1,926,677)   (2,189,009)   (6,367,670)   (13,232,205)
                     
OTHER EXPENSE                    
Interest expense   (247,310)   (254,313)   (741,461)   (762,235)
    (247,310)   (254,313)   (741,461)   (762,235)
                     
NET LOSS   (2,173,987)   (2,443,322)   (7,109,131)   (13,994,440)
                     
LESS: Accrued preferred dividends   (704,599)   (653,656)   (2,001,033)   (1,565,584)
                     
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS  $(2,878,586)  $(3,096,978)  $(9,110,164)  $(15,560,024)
                     
BASIC AND DILUTED NET LOSS PER
COMMON SHARE
  $(0.02)  $(0.02)  $(0.07)  $(0.12)
                    
BASIC AND DILUTED WEIGHTED AVERAGE
COMMON SHARES OUTSTANDING
   136,148,105    135,532,720    135,998,654    130,193,896 

 

See the accompanying notes to the condensed consolidated financial statements.

 

 6 

 

Rego Payment Architectures, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

For the Three and Nine Months Ended September 30, 2024 and September 30, 2023

(Unaudited)

 

   Preferred   Preferred   Preferred   Common                 
   Stock Series A   Stock Series B   Stock Series C   Stock   Additional             
   Number of       Number of       Number of       Number of       Paid-In   Accumulated   Noncontrolling     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Interests   Total 
                                                 
Balance, December 31, 2023   98,350   $10    234,403   $24    
-
   $
-
    135,848,105   $13,585   $104,707,296   $(136,110,967)  $
-
   $(31,390,052)
                                                             
Conversion of 10% secured convertible notes into Series B Preferred Stock   -    
-
    5,399    1    -    
-
    -    
-
    485,893    
-
    
-
    485,894 
Fair value of options for services   -    
-
    -    
-
    -    
-
    -    
-
    114,522    
-
    
-
    114,522 
Accrued preferred dividends   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (630,140)   
-
    (630,140)
Net loss   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (2,291,463)   
-
    (2,291,463)
                                                             
Balance, March 31, 2024   98,350   $10    239,802   $25    -   $
-
    135,848,105   $13,585   $105,307,711   $(139,032,570)  $
-
   $(33,711,239)
                                                             
Sale of Series B Preferred Stock   -    
-
    41,367    4    -    
-
    -    
-
    3,723,016    
-
    
-
    3,723,020 
Issuance of common stock to board members and employees   -    
-
    -    
-
    -    
-
    300,000    30    307,470    
-
    
-
    307,500 
Fair value of options for services   -    
-
    -    
-
    -    
-
    -    
-
    395,063    
-
    
-
    395,063 
Accrued preferred dividends   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (666,296)   
-
    (666,296)
Net loss   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (2,643,681)   
-
    (2,643,681)
                                                             
Balance, June 30, 2024   98,350   $10    281,169   $29    -   $
-
    136,148,105   $13,615   $109,733,260   $(142,342,547)  $
-
   $(32,595,633)
                                                             
Fair value of options for services   -    -    -    -    -    -    -    -    141,336    -    -    141,336 
Accrued preferred dividends   -    -    -    -    -    -    -    -    -    (704,599)   -    (704,599)
Net loss   -    -    -    -    -    -    -    -    -    (2,173,987)   -    (2,173,987)
                                                             
Balance, September 30, 2024   98,350   $10    281,169   $29    -   $-    136,148,105   $13,615   $109,874,596   $(145,221,133)  $-   $(35,332,883)

 

 

   Preferred   Preferred   Preferred   Common                 
   Stock Series A   Stock Series B   Stock Series C   Stock   Additional             
   Number of       Number of       Number of       Number of       Paid-In   Accumulated   Noncontrolling     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Interests   Total 
                                                 
Balance, December 31, 2022   100,350   $10    162,485   $17    
-
   $
-
    124,160,885   $12,416   $83,255,319   $(117,157,414)  $(97,704)  $(33,987,356)
                                                             
Conversion of Series A Preferred Stock into common stock   (2,000)   
-
    -    
-
    -    
-
    222,220    22    (22)   
-
    
-
    
-
 
Sale of Series B Preferred Stock   
-
    
-
    8,444    -    
-
    
-
    
-
    
-
    759,999    
-
    
-
    759,999 
Issuance of common stock to board members and employees   -    
-
    -    
-
    -    
-
    7,200,000    720    8,278,430    
-
    
-
    8,279,150 
Exercise of options   -    
-
    -    
-
    -    
-
    80,000    8    79,592    
-
    
-
    79,600 
Fair value of options for services   -    
-
    -    
-
    -    
-
    -    
-
    504,862    
-
    
-
    504,862 
Accrued preferred dividends   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (261,966)   (4,898)   (266,864)
Net loss   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (5,408,901)   
-
    (5,408,901)
                                                             
Balance, March 31, 2023   98,350   $10    170,929   $17    
-
   $
-
    131,663,105   $13,166   $92,878,180   $(122,828,281)  $(102,602)  $(30,039,510)
                                                             
Sale of Series B Preferred Stock   -    
-
    56,585    6    -    
-
    -    
-
    5,092,494    
-
    
-
    5,092,500 
Issuance of common stock to board members and employees   -    
-
    -    
-
    -    
-
    1,375,000    138    1,662,613    
-
    
-
    1,662,751 
Issuance of common stock to consultants   -    
-
    -    
-
    -    
-
    250,000    25    312,475    
-
    
-
    312,500 
Exercise of options   -    
-
    -    
-
    -    
-
    1,960,000    196    546,854    
-
    
-
    547,050 
Fair value of options for services   -    
-
    -    
-
    -    
-
    -    
-
    1,907,746    
-
    
-
    1,907,746 
Accrued preferred dividends   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (640,063)   (5,000)   (645,063)
Net loss   -    
-
    -    
-
    -    
-
    -    
-
    
-
    (6,142,217)   
-
    (6,142,217)
                                                             
Balance, June 30, 2023   98,350   $10    227,514   $23    -   $
-
    135,248,105   $13,525   $102,400,362   $(129,610,561)  $(107,602)  $(27,304,243)
                                                             
Sale of Series B Preferred stock   -    -    5,223    1    -    -    -    -    469,899    -    -    469,900 
Issuance of common stock to board members and employees   -    -    -    -    -    -    200,000    20    247,980    -    -    248,000 
Exercise of options   -    -    -    -    -    -    200,000    20    179,980    -    -    180,000 
Fair value of options for services   -    -    -    -    -    -    -    -    273,721    -    -    273,721 
Accrued preferred dividends   -    -    -    -    -    -    -    -    -    (648,656)   (5,000)   (653,656)
Net loss   -    -    -    -    -    -    -    -    -    (2,443,322)   -    (2,443,322)
                                                             
Balance, September 30, 2023   98,350   $10    232,737   $24    -   $-    135,648,105   $13,565   $103,571,942   $(132,702,539)  $(112,602)  $(29,229,600)

 

See the accompanying notes to the condensed consolidated financial statements

 

 7 

 

Rego Payment Architectures, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

  For the Nine Months Ended September 30, 
   2024   2023 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(7,109,131)  $(13,994,440)
Adjustments to reconcile net loss to net cash used in operating activities:          
Fair value of common stock issued in exchange for services   307,500    10,502,401 
Fair value of options issued in exchange for services   650,921    2,686,330 
Amortization   29,519    29,090 
Decrease (increase) in assets          
Prepaid expenses   (31,678)   (653)
Increase (decrease) in liabilities          
Accounts payable and accrued expenses   636,337    667,526 
Accounts payable and accrued expenses - related parties   13,153    9,744 
Common stock to be issued   
-
    (5,350,000)
           
Net cash used in operating activities   (5,503,379)   (5,450,002)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Investment in patents   (1,118)   (11,215)
Net cash used in investing activities   (1,118)   (11,215)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Exercise of options   
-
    806,650 
Proceeds from sale of Series B Preferred Stock   3,723,021    6,322,399 
           
Net cash provided by financing activities   3,723,021    7,129,049 
           
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (1,781,476)   1,667,832 
           
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD   6,256,634    6,005,667 
           
CASH AND CASH EQUIVALENTS - END OF PERIOD  $4,475,158   $7,673,499 
           
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
           
Cash paid during period for:          
Interest  $
-
   $
-
 
           
Income taxes  $
-
   $
-
 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:          
           
Accrued preferred dividends  $2,001,033   $1,565,583 
           
Conversion of Series A Preferred Stock to common stock  $
-
   $22 
           
Conversion of 10% secured convertible note payable and accrued interest into 5,399 shares of Series B Preferred Stock  $485,893   $
-
 

 

See the accompanying notes to the condensed consolidated financial statements.

 

 8 

 

Rego Payment Architectures, Inc.

Notes to Condensed Consolidated Financial Statements

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of the Business

 

REGO Payment Architectures, Inc. (“REGO”) was incorporated in the state of Delaware on February 11, 2008.

 

REGO Payment Architectures, Inc. and its subsidiaries (collectively, except where the context requires, the “Company”) is a provider of consumer software that delivers a mobile payment platform —Mazoola® - a family focused mobile banking solution. Headquartered in Blue Bell, Pennsylvania, the Company maintains a portfolio of trade secrets and four US patent awards. REGO offers an all-digital financial payments platform to enable minors, particularly under 13 years old, to purchase goods and services, complete chores and learn in a secure online environment guided by parental permission, oversight, and control, while remaining Children’s Online Privacy Protection Act (“COPPA”) and General Data Protection Regulation (“GDPR”) compliant.

 

Management believes that building on its COPPA advantage that the future of REGO Payment Architectures, Inc. will be based on the foundational architecture of its technology platform (the “Platform”) that will allow its use across multiple financial markets where secure controlled payments are needed. The Company intends to license in each alternative field of use the ability for its partners, distributors and/or value-added resellers to private label each of the alternative markets. These partners would deploy, customize and support each implementation under their own label, but with acknowledgement of the Company’s proprietary intellectual assets as the base technology. Management believes this approach will enable the Company to reduce expenses while broadening its reach.

 

Revenues generated from the Platform will come from multiple sources depending on the level of service and facilities requested by the parent. The Company’s model contemplates levels of subscription revenue paid monthly, service fees, transaction fees and revenue sharing and licensing with banking and distribution partners.

 

The Company’s principal office is located in Blue Bell, Pennsylvania.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the financial statements and have been prepared on a consistent basis using the accounting policies described in the summary of accounting policies included in the Company’s 2023 Annual Report on Form 10-K (the “Form 10-K”). All significant intercompany transactions and balances have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed, or omitted pursuant to such rules and regulations, although the Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

 

The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional financing to operationalize the Company’s current technology before another company develops or markets similar technology to compete with the Company.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

As of September 30, 2024, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.

 

 9 

 

NOTE 2 – MANAGEMENT PLANS

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant losses and experienced negative cash flow from operations since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Since inception, the Company has focused on developing and implementing its business plan. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. The Company currently needs to generate revenue in order to sustain its operations. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

 

The Company’s current monetization model is to derive revenues from levels of service fees, transaction fees and in some cases revenue sharing with banking and distribution partners. As these bases of revenues grow, the Company expects to generate additional revenue to support operations.

 

As of November 14, 2024, the Company has a cash position of approximately $3.9 million. Based upon the current cash position and the Company’s planned expense run rate, management believes the Company has funds currently to finance its operations on a limited basis through April 2025.

 

NOTE 3 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES - RELATED PARTIES

 

As of September 30, 2024 and December 31, 2023, the Company owed the Chief Executive Officer, who is also a more than 5% beneficial owner, a total of $10,096 and $1,328 in unpaid salary.

 

As of September 30, 2024 and December 31, 2023, the Company owed the Chief Financial Officer $5,116 and $731 in unpaid salary.

 

NOTE 4 – LOANS PAYABLE

 

Loans payable as of September 30, 2024 and December 31, 2023 were $42,600. Interest accrued on the loans at 6% and 10% was $11,955 and $9,731 as of September 30, 2024 and December 31, 2023. Interest expense related to these loans payable was $747 and $2,224 for the three and nine months ended September 30, 2024 and $747 and $2,216 for the three and nine months ended September 30, 2023.

 

NOTE 5 – 10% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

 

On March 6, 2015, the Company, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”), issued $2,000,000 aggregate principal amount of its 10% Secured Convertible Promissory Notes due March 5, 2016 (the “Notes”) to certain stockholders. On May 11, 2015, the Company issued an additional $940,000 of Notes to stockholders. The maturity dates of the Notes have been extended most recently to December 31, 2024 with consent of the Note holders.

 

The Notes are convertible by the holders, at any time, into shares of the Company’s Series B Preferred Stock at a conversion price of $90.00 per share, subject to adjustment for stock splits, stock dividends and similar transactions with respect to the Series B Preferred Stock only. Each share of Series B Preferred Stock is currently convertible into 100 shares of the Company’s common stock at a current conversion price of $0.90 per share, subject to anti-dilution adjustment as described in the Certificate of Designation of the Series B Preferred Stock. In addition, pursuant to the terms of a Security Agreement entered into on May 11, 2015 by and among the Company, the Note holders and a collateral agent acting on behalf of the Note holders (the “Security Agreement”), the Notes are secured by a lien against substantially all of the Company’s business assets. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series B Preferred Stock upon a conversion of the Notes.

 

 10 

 

The Notes are recorded as a current liability as of September 30, 2024 and December 31, 2023 in the amount of $3,036,237 and $3,316,357. Interest accrued on the Notes was $2,864,818 and $2,842,873 as of September 30, 2024 and December 31, 2023. Interest expense related to these Notes payable was $75,906 and $227,718 for the three and nine months ended September 30, 2024 and $82,909 and $248,727 for the three months and nine months ended September 30, 2023.

 

During the nine months ended September 30, 2024, a 10% Secured Convertible Noteholder converted $280,120 of principal plus $205,773 of accrued interest into 5,399 shares of Series B Preferred Stock.

 

NOTE 6 – NOTES PAYABLE – STOCKHOLDERS

 

These notes payable have no formal repayment terms and $370,000 of the notes bear interest at 10% per annum and the remaining $225,000 of the notes bear interest at 20% per annum.

 

These notes payable are recorded as a current liability as of September 30, 2024 and December 31, 2023 in the amount of $595,000. Interest accrued on the notes, as of September 30, 2024 and December 31, 2023 was $424,593 and $361,026. Interest expense, including accretion of discounts, and warrants issued related to these notes payable was $22,330 and $63,567 for the three and nine months ended September 30, 2024 and $20,845 and $61,855 for the three and nine months ended September 30, 2023.

 

NOTE 7 – 4% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

 

On August 26, 2016, the Company, pursuant to a Securities Purchase Agreement, issued $600,000 aggregate principal amount of its 4.0% Secured Convertible Promissory Notes due June 30, 2019 (the “New Secured Notes”) to certain accredited investors (“investors”). The Company issued additional New Secured Notes during the years 2016 through 2022.

 

The New Secured Notes are convertible by the holders, at any time, into shares of the Company’s authorized Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”) at a conversion price of $90.00 per share, subject to adjustment for stock splits, stock dividends and similar transactions with respect to the Series C Preferred Stock only. Each share of Series C Preferred Stock is currently convertible into 100 shares of the Company’s common stock at a current conversion price of $0.90 per share, subject to full ratchet anti-dilution adjustment for one year and weighted average anti-dilution adjustment thereafter, as described in the Certificate of Designation of the Series C Preferred Stock. Upon a liquidation event, the Company shall first pay to the holders of the Series C Preferred Stock, on a pari passu basis with the holders of the Company’s outstanding Series A Preferred Stock and Series B Preferred Stock, an amount per share equal to 700% of the conversion price (i.e., $630.00 per share of Series C Preferred Stock), plus all accrued and unpaid dividends on each share of Series C Preferred Stock (the “Series C Preference Amount”). The Series C Preference Amount shall be paid prior and in preference to payment of any amounts to the Common Stock. After the payment of all preferential amounts required to be paid to the holders of shares of Series C Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and any additional senior preferred stock, the Series C Preferred Stock participates in further distributions subject to an aggregate cap of seven and one-half times (7.5x) the original issue price thereof, plus all accrued and unpaid dividends.

 

The maturity dates of the New Secured Notes were extended by the investors most recently to December 31, 2024.

 

The New Secured Notes are recorded as a current liability in the amount of $14,981,250 as of September 30, 2024 and December 31, 2023. Interest accrued on the New Secured Notes was $3,199,136 as of September 30, 2024 and $2,749,699, as of December 31, 2023. Interest expense, including the accretion of discounts related to these New Secured Notes was $149,813 and $449,437 for the three and nine months ended September 30, 2024 and September 30, 2023.

 

 11 

 

NOTE 8 – INCOME TAXES

 

Income tax expense was $0 for the three and nine months ended September 30, 2024 and 2023.

 

As of January 1, 2024, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2024 related to unrecognized tax benefits. There has been no change in unrecognized tax benefits during the three and nine months ended September 30, 2024, and there was no accrual for uncertain tax positions as of September 30, 2024. Tax years from 2020 through 2023 remain subject to examination by major tax jurisdictions.

 

There is no income tax benefit for the losses for the three and nine months ended September 30, 2024 and 2023, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.

 

NOTE 9 – CONVERTIBLE PREFERRED STOCK

 

Rego Payment Architectures, Inc. Series A Preferred Stock

 

The Series A Preferred Stock has a preference in liquidation equal to two times its original issue price, or $19,670,000, to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 2.5 times its original issue price. The Series A Preferred stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series A Preferred Stock can be converted. The Series A Preferred Stock also contains customary approval rights with respect to certain matters. The Series A Preferred Stock accrues dividends at the rate of 8% per annum or $8.00 per Series A Preferred Share.

 

The conversion price of Series A Preferred Stock is currently $0.90 per share. The Series A Preferred Stock is subject to mandatory conversion if certain registration or related requirements are satisfied and the average closing price of the Rego’s common stock exceeds 2.5 times the conversion price over a period of twenty consecutive trading days.

 

Rego Payment Architectures, Inc. Series B Preferred Stock

 

The Series B Preferred Stock is pari passu with the Series A Preferred Stock and has a preference in liquidation equal to two times its original issue price, or $50,610,420 as of September 30, 2024, to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 2.5 times its original issue price. The Series B Preferred stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series B Preferred Stock can be converted. The Series B Preferred Stock also contains customary approval rights with respect to certain matters. The Series B Preferred Stock accrues dividends at the rate of 8% per annum.

 

The conversion price of the Series B Preferred Stock is currently $0.90 per share. The Series B Preferred Stock is subject to mandatory conversion if certain registration or related requirements are satisfied and the average closing price of the Company’s common stock exceeds 2.5 times the conversion price over a period of twenty consecutive trading days.

 

During the nine months ended September 30, 2024 and 2023, the Company sold 41,367 and 70,252 shares of the Company’s Series B Preferred Stock in private placements to accredited investors and received proceeds of $3,723,021 and $6,322,400.

 

Rego Payment Architectures, Inc. Series C Preferred Stock

 

In August 2016, Rego authorized 150,000 shares of Rego’s Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”). On August 23, 2021, Rego filed with the Delaware Secretary of State an Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series C Cumulative Convertible Preferred Stock, pursuant to which the amount of authorized Series C Preferred Stock was increased from 150,000 shares to 300,000 shares. As of September 30, 2024, none of the Series C Preferred Stock was issued or outstanding. After the date of issuance of Series C Preferred Stock, dividends at the rate of $7.20 per share will begin accruing and will be cumulative. The Series C Preferred Stock is pari passu with the Series A Preferred Stock and Series B Preferred Stock and has a preference in liquidation equal to seven times its original issue price to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 7.5 times its original issue price. The Series C Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series C Preferred Stock can be converted. The Series C Preferred Stock also contains customary approval rights with respect to certain matters. There are no outstanding Series C Preferred Shares, therefore the current per annum dividend per share is $0.

 

 12 

 

As of September 30, 2024, the value of the cumulative 8% dividends for all Rego preferred stock was $13,268,823. Such dividends will be paid when and if declared payable by Rego’s board of directors or upon the occurrence of certain liquidation events. In accordance with FASB ASC 260-10-45-11, the Company has recorded these accrued dividends as a current liability.

 

NOTE 10 – STOCKHOLDERS’ EQUITY

 

On February 22, 2024, the Company engaged a merchant bank in a consultative capacity to advise on capital funding and strategic initiatives which include the prospective sale of the Company. The Company will pay a fee equal to 1.5% of the transaction value upon closing. This contingency has not yet been met as of September 30, 2024.

 

Option Amendments and Adjustments

 

On January 2, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 300,000 shares of common stock of the Company at an exercise price of $0.90 per share. These options were scheduled to expire in January 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $66,705 which was expensed during the three months ended March 31, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 62.8%, risk free interest rate of 4.33%, and expected option life of 2.0 years.

 

On March 29, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 125,000 shares of common stock of the Company at an exercise price of $1.31 per share. These options were scheduled to expire in April 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $17,806 which was expensed during the three months ended March 31, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 58.7%, risk free interest rate of 4.59%, and expected option life of 2.0 years.

 

On June 10, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 900,000 shares of common stock of the Company at exercise prices ranging from $0.90 to $1.25 per share. These options were scheduled to expire in the second and third quarter of 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $220,647 which was expensed during the three months ended June 30, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 61.5%, risk free interest rate of 4.87%, and expected option life of 1.5 years.

 

On September 23, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 652,125 shares of common stock of the Company at exercise prices ranging from $1.22 to $1.70 per share. These options were scheduled to expire in the fourth quarter of 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $90,869 which was expensed during the three months ended September 30, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 60.8%, risk free interest rate of 3.91%, and expected option life of 1.25 years.

 

 13 

 

Issuance of Restricted Shares

 

A restricted stock award (“RSA”) is an award of common shares that is subject to certain restrictions during a specified period. Restricted stock awards are independent of option grants and are generally subject to forfeiture if employment terminates prior to the release of the restrictions. The grantee cannot transfer the shares before the restricted shares vest. Shares of nonvested restricted stock have the same voting rights as common stock, are entitled to receive dividends and other distributions thereon and are considered to be currently issued and outstanding. The Company’s restricted stock awards generally vest over a period of one year. The Company expenses the cost of the restricted stock awards, which is determined to be the fair market value of the shares at the date of grant, straight-line over the period during which the restrictions lapse. For these purposes, the fair market value of the restricted stock is determined based on the closing price of the Company’s common stock on the grant date.

 

NOTE 11 – STOCK OPTIONS AND WARRANTS

 

During 2008, the Board of Directors (“Board”) of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the stockholders. Under the 2008 Plan, the Company was authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company. The 2008 Plan was intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). As of September 30, 2024, under the 2008 Plan, options to purchase 200,000 shares of common stock remain outstanding and are unexercised, and no shares are available for grants under the 2008 Plan. The 2008 Plan expired on March 3, 2019.

 

During 2013, the Board adopted the 2013 Equity Incentive Plan (“2013 Plan”), which was approved by stockholders at the 2013 annual meeting of stockholders. Under the 2013 Plan, the Company was authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013 Plan was intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options. As of September 30, 2024, under the 2013 Plan, grants of restricted stock and options to purchase 1,200,000 shares of common stock remain outstanding and are unexercised, and no shares of common stock remained available for grants under the 2013 Plan. The 2013 Plan expired on November 18, 2023.

 

The Company also grants stock options outside the option plans on terms determined by the Board.

 

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

 

Prior to January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company. Beginning January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the historical volatility of the Company’s common stock.

 

The following table presents the weighted-average assumptions used to estimate the fair values of the stock options granted by REGO during the nine months ended September 30, 2024:

 

Risk Free Interest Rate   4.7%
Expected Volatility   60.9%
Expected Life (in years)   2.0 
Dividend Yield   0%
Weighted average estimated fair value of options during the period  $0.37 

 

During the nine months ended September 30, 2024, the Company issued options to purchase 611,150 shares of the Company’s common stock to various consultants and employees. The options were valued at $245,055 fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options. The fair value of options was expensed immediately.

 

 14 

 

The following table summarizes the activities for REGO’s stock options for the nine months ended September 30, 2024:

 

    Options Outstanding 
             Weighted -      
             Average       
             Remaining   Aggregate 
        Weighted-   Contractual   Intrinsic 
   Number of   Average    Term   Value 
   Shares   Exercise Price   (in years)   (in 000's) (1) 
Balance, December 31, 2023   14,320,000   $0.90    1.5   $8,416 
                     
Granted   611,150    1.03    1.7    
-
 
Exercised   
-
    
-
    
-
    
-
 
Expired/Cancelled   (747,500)   0.90    
-
    
-
 
                     
Balance, September 30, 2024   14,183,650   $0.86    1.1   $3,306 
                     
Exercisable at September 30, 2024 and expected to vest thereafter   14,183,650   $0.86    1.1   $3,306 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $1.05 for the Company’s common stock on September 30, 2024.

 

REGO expensed $131,497 and $650,921 for the three and nine months ended September 30, 2024 and $273,721 and $2,686,330 for the three and nine months ended September 30, 2023 with respect to stock options.

 

As of September 30, 2024, there was $0 of unrecognized compensation cost related to outstanding stock options. The difference, if any, between the stock options exercisable at September 30, 2024 and the stock options exercisable and expected to vest relates to management’s estimate of options expected to vest in the future.

 

NOTE 12 – OPERATING LEASES

 

For the three and nine months ended September 30, 2024 total rent expense under short-term leases amounted to $1,315 and $3,970 and for the three and nine months ended September 30, 2023 total rent under short-term leases amounted to $5,017 and $7,500. The Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases. The Company has no long-term lease obligations as of September 30, 2024.

 

NOTE 13 – RELATED PARTY TRANSACTIONS

 

On March 1, 2024, the Chief Executive Officer and the Chief Financial Officer each received cash bonuses of $30,000 for a total of $60,000 in aggregate.

 

On May 16, 2024 the following performance bonuses were earned pursuant the successful completion of the Series B Preferred financing accomplished via a final $3.5 million private placement: 1) Shares of Common Stock: Chief Executive Officer: 300,000 shares; 2) Cash Compensation: Chairman: $50,000; Chief Executive Officer: $50,000; and Chief Financial Officer: $30,000. For the Common Stock award, the Company recorded share-based compensation expense of $307,500, the fair value of the Common Stock issued, in May 2024.

 

 15 

 

NOTE 14 - INVESTOR PRIVATE LINE OF CREDIT

 

On March 13, 2023, the Company entered into an Investor Private Line of Credit agreement (the “LOC Agreement”) with an existing shareholder of the Company (the “Lender”). Pursuant to this agreement, the Lender may extend unsecured loans to the Company in the amount of up to twenty million dollars ($20,000,000) which may be drawn upon by the Company for a period of one year in order to provide additional capital to facilitate the Company’s operations. Drawings may be made by the Company as long as there has not been any material change in the operations of the Company. Loans under the LOC Agreement bear interest at the rate of 7% per annum. Drawings under the LOC Agreement must be repaid in full:(i) upon the execution and completion of a sale, merger or other transaction of the Company whereby the Company transfers its ownership and/or its assets to a third party within thirty (30) days of the completion of the transaction (a “Change of Control”) or (ii) if a Change of Control does not occur within one year from the date of the LOC Agreement, the Company will repay any amounts outstanding within sixty (60) days.

 

On March 13, 2024, the Company entered into an Amendment to Investor Private Line of Credit (the “Amendment”) with the Lender. The Amendment extended the maturity date of the existing Investor Private Line of Credit Agreement with the Lender by one year, from March 13, 2024 to March 13, 2025.

 

As of September 30, 2024 the outstanding balance on this LOC Agreement is $0.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Overview

 

REGO Payment Architectures, Inc. is a provider of consumer software that delivers a mobile payment platform— Mazoola® - a family focused mobile banking solution. Headquartered in Blue Bell, Pennsylvania, the Company maintains a portfolio of trade secrets and four US patent awards. REGO offers an all-digital financial payments platform to enable minors, particularly under 13 years old, to transact, complete chores and learn in a secure online environment guided by parental permission, oversight, and control, while remaining COPPA and GDPR compliant.

 

COPPA applies not only to websites and mobile apps. It can apply to a growing list of connected devices that is included in the Internet of Things. Some of these include toys and products that could collect personal information, such as voice recordings or geolocation information. Non-compliance with COPPA has meant substantial fines for many violators.

 

Management believes that by building on its COPPA compliance advantage, the future of REGO Payment Architectures, Inc. will be based on the foundational architecture of its software platform (the “Platform”) that will allow its use across multiple financial markets where secure controlled payments are needed. The Company intends to license in each alternative field of use the ability for its partners, distributors and/or value-added resellers to private label each of the alternative markets. These partners will deploy, customize and support each implementation under their own label, but with acknowledgement of the Company’s proprietary intellectual assets as the base technology. Management believes this approach will enable the Company to reduce marketing expenses while broadening its reach.

 

Further, California passed the California Consumer Privacy Act of 2018 (“CCPA”) on June 28, 2018. CCPA gives consumers (defined as natural citizens who are California residents) four rights relative to their personal information as follows:

 

the right to know, through a general privacy policy and with more specifics available upon request, what personal information a business has collected about them, where it was sourced from, what it is being used for, whether it is being disclosed or sold, and to whom it is being disclosed or sold;

 

the right to “opt out” of allowing a business to sell their personal information to third parties (or, for consumers who are under 16 years old, the right not to have their personal information sold absent their, or their parent’s, opt-in);

 

 16 

 

the right to have a business delete their personal information, with some exceptions; and

 

the right to receive equal service and pricing from a business, even if they exercise their privacy rights under the CCPA.

 

With respect to the evolving CCPA, the Company has designed its Platform and app to be in compliance.

 

Additionally, the European Parliament and Council agreed upon the General Data Protection Regulation (“GDPR”) in April 2016, to replace the Data Protection Directive 95/46/EC. This is the primary law regulating how companies protect European Union (“EU”) citizens’ personal data. GDPR became effective on May 25, 2018. Companies that fail to achieve GDPR compliance are subject to severe fines and penalties.

 

GDPR requirements apply to each member state of the European Union, aiming to create more consistent protection of consumer and personal data across EU nations. Some of the key privacy and data protection requirements of the GDPR include:

 

Requiring the consent of subjects for data processing

 

Anonymizing collected data to protect privacy

 

Providing data breach notifications

 

Safely handling the transfer of data across borders

 

Requiring certain companies to appoint a data protection officer to oversee GDPR compliance

 

In short, the handling of EU citizens’ data is mandated by GDPR using a baseline set of standards for companies that are designed to better safeguard the processing and movement of personal data. The Company has designed its Platform and app to be in compliance with GDPR, and has received the GDPRkidsTM Trustmark from PRIVO.

 

Revenues generated from the Platform will come from multiple sources depending on the level of service and facilities requested. There will be levels of subscription revenue paid monthly, service fees, transaction fees and in some cases, revenue sharing and licensing with banking and distribution partners.

 

Our goal, moving forward, is to enable both incumbent and new financial technology (“FinTech”) participants, as well as key verticals with a large base of ‘family accounts,’ to provide their consumers with safe and empowering youth money management and financial literacy content and tools via the mobile payment platform.

 

While some of the REGO Platform can be easily duplicated/commoditized, such as the app skin, APIs to retailers, APIs to financial infrastructure and cloud storage, we believe that defending our market position rests on three factors:

 

1.The ability to define data control settings from parent to child.

 

Our approach to this opportunity uses a master account to dictate purchase rules to sub-accounts via a hierarchical architecture. This approach adheres to data flow and privacy policy requirements specifically outlined for COPPA compliance. We believe other approaches based on machine learning, or other artificial intelligence methodologies are potentially viable alternatives but are likely too costly, do not meet current compliance timelines, and may defy the core of COPPA’s “opt-in” parameters. There is considerable room for next-generation automation techniques to be layered on REGO’s hierarchical approach. Given its current stability and scalability metrics, the REGO Platform strongly features these advances in its technical development roadmap without compromising any of its current data control performance.

 

2.The ability to (mis)attribute the child’s transaction and personal identification.

 

REGO has solved this issue by masking user data and maintaining separate identity and financial data flows. As a result, REGO can verify the age of the internet user through the transaction lifecycle on its Platform. Authenticating and validating the identity of the actual user on the internet remains one of the more difficult cybersecurity challenges. Current approaches are mainly not for commercial use; however, there is investment in commercial innovation in this area. REGO’s data control features and its (mis)attribution approach are inextricably linked and a key to its scalability and extensibility.

 

 17 

 

3.The ability to disseminate transactional data on minors while remaining COPPA and GDPR compliant.

 

The highest value data will be that which shows the most nuanced detail afforded under current regulations. Without extreme data control features, such as in the REGO Platform, any lesser data precision will be less valuable.

 

These three factors are all supported by REGO’s patented technology.

 

REGO addresses hard industry problems such as:

 

COPPA compliant technology with a key component being its ability to verify the age of an internet user

 

A master and sub-account architecture with the ability to administer user-specific controls

 

An advanced rules engine to provide strict automated compliance of the parental rules for each child

 

Near real-time buying behavior database on minors - anonymized geolocation, age range and purchases

 

Currently, we are targeting established brands with large family-focused account bases — including banks, telecommunication companies, faith-based organizations, media distributors, mobile device Original Equipment Manufacturers (“OEMs”), and merchants.

 

We are seeking partners that will leverage our Platform to:

 

Buy vs. Build: Partners can license or revenue share for their specific market or field of use a safe, compliant system, instead of building one on their own.

 

Safety & Security: Partners can safely engage a younger consumer segment and their families with a new family friendly peer-to-peer-payment approach. Vendors will be explicitly protected from non-compliant transactions and the underlying technology protects the privacy of the user.

 

Youth Financial Literacy: Partners can expand their brand story around empowerment and education of youth financial literacy while engaging their ‘future customers’ with Gen Z, a digital native population of post-millennial youth.

 

The REGO Mazoola® app and associated digital wallet technology is designed to enable our partners to engage families with Gen Z and Gen Alpha youths through a money management, transactional and financial literacy platform that enables young people to make smart decisions about the things they value in life — including their money, their time, their ideas and their connections. The Mazoola® app enables a new way for individual users to own and monetize their purchasing behavior that is currently unavailable to them.

 

In addition, we are analyzing specific components of our technology for individual monetization as well as exploring opportunities in the Business to Business (“B2B”) realm.

 

Other markets for potential licensed applications are:

 

Government social services payments where control over how benefits allowances are used is required. This is particularly necessary in some European countries where social benefits are not being used as intended by the government or where benefits are subject to fraud.

 

 18 

 

Closed network consumer to business (C2B) and business to business (B2B). An example is school lunch programs where the consumer can make direct mobile payments to the provider’s point of sale (POS) terminal without the need to traverse the traditional merchant payment system. This reduces the cost per transaction for the vendor and provides instant non-repudiated settlement. Many school lunch programs are now provided by large catering companies. This is particularly valuable as credit card fees, transaction fees and service fees can exceed 3% in overhead costs per transaction dependent on the negotiated rate. Removing this overhead can have significant positive financial impact on profitably. It also allows the closed network to own its own behavioral use data thus obviating the need to pay a third party for the same data.

 

Integration of our certified COPPA-compliant white label Family Wallet Banking-as-a-Platform into digital banking platforms. This will make the Company's family wallet available to financial institutions which will allow end-user customers of subscribing financial institutions to utilize the Company's family wallet.

 

We believe that our near-term success will depend particularly on our ability to develop customer awareness and confidence in our service. Since we have extremely limited capital resources, we will need to closely manage our expenses and conserve our cash by continually monitoring any increase in expenses and reducing or eliminating unnecessary expenditures. Our prospects must be considered in light of the risks, expenses and difficulties encountered by companies at an early stage of development, particularly given that we operate in new and rapidly evolving markets, that we have limited financial resources, and face an uncertain economic environment. We may not be successful in addressing such risks and difficulties.

 

Results of Operations

 

Comparison of the Three Months Ended September 30, 2024 and 2023

 

The following discussion analyzes our results of operations for the three months ended September 30, 2024 and 2023. The following information should be considered together with our condensed financial statements for such periods and the accompanying notes thereto.

 

Net Revenue

 

We have not generated significant revenue since our inception. For the three months ended September 30, 2024 and 2023, we generated revenues of $0 and $0.  

 

Net Loss 

 

For the three months ended September 30, 2024 and 2023, we had a net loss of $2,173,987 and $2,443,322.

 

Transaction Expense

 

Transaction expense for the three months ended September 30, 2024 was $86,955 compared to $56,581 for the three months ended September 30, 2023. These are transactional charges primarily for the operation of the Mazoola® app. The increase is attributed to higher costs associated with a new Platform provider implemented in 2024.

 

Sales and Marketing

 

Sales and marketing expenses for the three months ended September 30, 2024 were $116,605 compared to $468,115 for the three months ended September 30, 2023, a decrease of $351,510. The decrease is attributed to the elimination and replacement of certain marketing consultants with more cost-effective service providers along with lower marketing options expense in 2024 as compared to the three months ended September 30, 2023.

 

Product Development

 

Product development expenses were $912,706 and $758,614 for the three months ended September 30, 2024 and 2023, an increase of $154,092. This was primarily a result of increased cyber-security and SOC2 costs incurred in 2024 which were not incurred during the three months ended September 30, 2023. Also, payroll costs increased as a result of a Product Development new hire in September 2024.

 

 19 

 

General and Administrative Expenses

 

General and administrative expenses decreased $95,288 to $810,411 for the three months ended September 30, 2024 from $905,699 for the three months ended September 30, 2023. The decrease resulted from lower payroll costs and professional fees which were partially offset by increases to Board and consulting fees for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023.

 

Interest Expense

 

During the three months ended September 30, 2024 and September 30, 2023, the Company incurred interest expense of $247,310 and $254,313. No new Notes were issued over the prior twelve-month period. However, interest expense is slightly lower for the three months ended September 30, 2024 when compared to the three months ended September 30, 2023 since a 10% Secured Convertible Noteholder converted $280,120 of principal plus $205,773 of accrued interest into 5,399 shares of Series B Preferred Stock on January 1, 2024.

 

Dividend Accrual

 

Accrued preferred dividend expense increased by $50,943 to $704,599 for the three months ended September 30, 2024 compared to $653,656 for the three months ended September 30, 2023. The expense increased as a result of the additional Series B Preferred Stock sold since September 30, 2023.

 

Comparison of the Nine Months Ended September 30, 2024 and 2023

 

The following discussion analyzes our results of operations for the nine months ended September 30, 2024 and 2023. The following information should be considered together with our condensed financial statements for such periods and the accompanying notes thereto.

 

Net Revenue

 

We have not generated significant revenue since our inception. For the nine months ended September 30, 2024 and 2023, we generated revenues of $0 and $0.

 

Net Loss 

 

For the nine months ended September 30, 2024 and 2023, we had a net loss of $7,109,131 and $13,994,440.

 

Transaction Expense

 

Transaction expense for the nine months ended September 30, 2024 was $287,288 compared to $171,543 for the nine months ended September 30, 2023, an increase of $115,745. These are transactional charges primarily for the operation of the Mazoola® app. The increase is attributed to higher costs associated with a new Platform provider implemented in 2024.

 

Sales and Marketing

 

Sales and marketing expenses for the nine months ended September 30, 2024 were $526,065 compared to $1,475,458 for the nine months ended September 30, 2023, a decrease of $949,393. The decrease is attributed to the elimination and replacement of certain marketing consultants with more cost-effective service providers along with a decrease in marketing options expense in 2024 as compared to the nine months ended September 30, 2023.

 

Product Development

 

Product development expenses were $2,592,996 and $2,051,020 for the nine months ended September 30, 2024 and 2023, an increase of $541,976. The increase is due additional programming costs, cyber-security costs, compliance costs, new product development costs, white label integration costs, and additional payroll expense all associated with the ramp up of integrations with channel providers and new product development. These were new costs incurred during the nine months ended September 30, 2024 and not incurred for the nine months ended September 30, 2023.

 

 20 

 

General and Administrative Expenses

 

General and administrative expenses decreased $6,572,863 to $2,961,321 for the nine months ended September 30, 2024 from $9,534,184 for the nine months ended September 30, 2023. The Company expensed approximately $3,750,000 for stock grants to officers and directors during the nine months ended September 30, 2023 which did not occur during the nine months ended September 30, 2024. Additionally, a $300,000 increase to consultant fees was offset by a $1,900,000 decrease in consulting options expense, a $600,000 decrease in professional fees, a $500,000 decrease in payroll costs, and a $100,000 decrease in board fees for the nine months ended September 30, 2024 when compared to the nine months ended September 30, 2023.

 

Interest Expense

 

During the nine months ended September 30, 2024, the Company incurred interest expense of $741,461 compared to $762,235 for the nine months ended September 30, 2023, a decrease of $20,774. No new Notes were issued over the prior twelve-month period. However, interest expense is slightly lower for the nine months ended September 30, 2024 when compared to the nine months ended September 30, 2023 since a 10% Secured Convertible Noteholder converted $280,120 of principal plus $205,773 of accrued interest into 5,399 shares of Series B Preferred Stock on January 1, 2024.

 

Dividend Accrual

 

Accrued preferred dividend expense increased by $435,449 to $2,001,033 for the nine months ended September 30, 2024 compared to $1,565,584 for the nine months ended September 30, 2023. The expense increased as a result of the additional Series B Preferred Stock sold since September 30, 2023.

 

Liquidity and Capital Resources

 

As of November 14, 2024 we had cash on hand of approximately $3.9 million.

 

Net cash used in operating activities increased $53,377 to $5,503,379 for the nine months ended September 30, 2024 as compared to $5,450,002 for the nine months ended September 30, 2023. The increase resulted primarily from the change in the fair value of options and the fair value of common stock issued in exchange for services offset by an increase in prepaid expenses and a decrease in accounts payable-accrued expenses as compared to that of the same period in the prior year.

 

Net cash used in investing activities decreased to $1,118 for the nine months ended September 30, 2024 from $11,215 for the nine months ended September 30, 2023 as a result of a decrease in patents and trademarks expense.

 

Net cash provided by financing activities decreased to $3,723,021 for the nine months ended September 30, 2024 from $7,129,049 for the nine months ended September 30, 2023. Proceeds from the sale of Series B Preferred Stock and the exercise of options decreased when compared to the prior year.

 

As we have not realized significant revenues since our inception, we have financed our operations through offerings of debt and equity securities. On March 13, 2023, the Company entered into a $20 million Investor Private Line of Credit agreement with an existing shareholder of the Company. On March 13, 2024, the Company entered into an Amendment to the LOC (the “Amendment”) with the Lender. The Amendment extended the maturity date of the existing LOC with the Lender by one year, from March 13, 2024 to March 13, 2025. As of September 30, 2024 the outstanding balance on this LOC is $0.

 

 21 

 

Since our inception, we have focused on developing and implementing our business plan.  We believe that our existing cash resources will not be sufficient to sustain our operations during the next twelve months.  We currently need to generate sufficient revenues to support our cost structure to enable us to pay ongoing costs and expenses as they are incurred, finance enhancements to our Platform, and execute the business plan.  If we cannot generate sufficient revenue to fund our business plan, we intend to seek to raise such financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders. The issuance of convertible debt may also result in dilution to existing stockholders. If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to us, we will be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on our business, financial condition and results of operations. See Note 2 to our consolidated financial statements included in this Form 10-Q. 

 

Even if we are successful in generating sufficient revenue or in raising sufficient capital in order to commercialize the Platform, our ability to continue in business as a viable going concern can only be achieved when our revenues reach a level that sustains our business operations.  We do not project that significant revenue will be developed at the earliest until the first quarter of 2025. There can be no assurance that we will raise sufficient proceeds, or any proceeds, for us to implement fully our proposed business plan.  Moreover, there can be no assurance that even if the Platform is fully developed and successfully commercialized, that we will generate revenues sufficient to fund our operations.  In either such situation, we may not be able to continue our operations and our business might fail.

 

Based upon the current cash position and the Company’s planned expense run rate, management believes the Company will not be able to finance its operations on a limited basis beyond April 2025.

 

The foregoing forward-looking information was prepared by us in good faith based upon assumptions that we believe to be reasonable. No assurance can be given, however, regarding the attainability of the projections or the reliability of the assumptions on which they are based. The projections are subject to the uncertainties inherent in any attempt to predict the results of our operations, especially where new products and services are involved. Certain of the assumptions used will inevitably not materialize and unanticipated events will occur. Actual results of operations are, therefore, likely to vary from the projections and such variations may be material and adverse to us. Accordingly, no assurance can be given that such results will be achieved. Moreover, due to changes in technology, new product announcements, competitive pressures, system design and/or other specifications we may be required to change the current plans. 

 

Off-Balance Sheet Arrangements

 

As of September 30, 2024, we do not have any off-balance sheet arrangements.

 

Critical Accounting Policies

 

Our financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during their preparation. A complete summary of these policies is included in Note 1 of the Notes to Financial Statements included in the Company’s Form 10-K for the year ended December 31, 2023. We have identified below the accounting policies that are of particular importance in the presentation of our financial position, results of operations and cash flows and which require the application of significant judgment by management.

 

Stock-based Compensation

 

We have adopted the fair value recognition provisions of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 718. In addition, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 “Share-Based Payment” (“SAB 107”), which provides supplemental FASB ASC 718 application guidance based on the views of the SEC. Under FASB ASC 718, compensation cost recognized includes compensation cost for all share-based payments granted, based on the grant date fair value estimated in accordance with the provisions of FASB ASC 718.

 

We have used the Black-Scholes option-pricing model to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are, expected stock price volatility, the expected pre-vesting forfeiture rate and the expected option term (the amount of time from the grant date until the options are exercised or expire).

 

 22 

 

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued.  Non-employee equity-based payments that do not vest immediately upon grant are recorded as an expense over the vesting period.

 

Revenue Recognition

 

In accordance with FASB ASC 606, Revenue from Contracts with Customers, the Company recognizes revenue when it satisfies performance obligations, by transferring promised goods or services to customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for fulfilling those performance obligations.

 

Recently Issued Accounting Pronouncements

 

Recently issued accounting pronouncements are discussed in Note 1 of the Notes to Financial Statements contained elsewhere in this report. 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not required.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

As of September 30, 2024 we carried out the evaluation of the effectiveness of our disclosure controls and procedures required by Rule 13a-15(e) under the Exchange Act under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2024, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

There has been no change in our internal control over financial reporting that occurred during our fiscal quarter ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

There have been no material developments since the disclosure provided in the Company’s Form 10-K for the year ended December 31, 2023.

 

ITEM 1A. RISK FACTORS.

 

Not required. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

 23 

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS

 

31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
Exhibit 101.INS   XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
Exhibit 101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
Exhibit 101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
Exhibit 101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
Exhibit 101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
Exhibit 101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
Exhibit 104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 24 

 

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  REGO PAYMENT ARCHITECTURES, INC.  
       
  By: /s/ Joseph R. Toczydlowski  
    Joseph R. Toczydlowski  
   

Chief Financial Officer

(Duly Authorized Officer and

Principal Financial Officer)

 
Date: November 14, 2024      

 

 

25

 

 

 

false --12-31 Q3 0001437283 true NONE 0001437283 2024-01-01 2024-09-30 0001437283 2024-11-14 0001437283 2024-09-30 0001437283 2023-12-31 0001437283 us-gaap:RelatedPartyMember 2024-09-30 0001437283 us-gaap:RelatedPartyMember 2023-12-31 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2024-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2023-12-31 0001437283 rpmt:FourPercentageSecuredConvertibleNotesPayableMember 2024-09-30 0001437283 rpmt:FourPercentageSecuredConvertibleNotesPayableMember 2023-12-31 0001437283 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001437283 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001437283 us-gaap:SeriesBPreferredStockMember 2024-09-30 0001437283 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001437283 us-gaap:SeriesCPreferredStockMember 2024-09-30 0001437283 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001437283 2024-07-01 2024-09-30 0001437283 2023-07-01 2023-09-30 0001437283 2023-01-01 2023-09-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001437283 us-gaap:CommonStockMember 2023-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001437283 us-gaap:RetainedEarningsMember 2023-12-31 0001437283 us-gaap:NoncontrollingInterestMember 2023-12-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001437283 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001437283 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001437283 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001437283 2024-01-01 2024-03-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001437283 us-gaap:CommonStockMember 2024-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001437283 us-gaap:RetainedEarningsMember 2024-03-31 0001437283 us-gaap:NoncontrollingInterestMember 2024-03-31 0001437283 2024-03-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001437283 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001437283 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001437283 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001437283 2024-04-01 2024-06-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001437283 us-gaap:CommonStockMember 2024-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001437283 us-gaap:RetainedEarningsMember 2024-06-30 0001437283 us-gaap:NoncontrollingInterestMember 2024-06-30 0001437283 2024-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001437283 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001437283 us-gaap:CommonStockMember 2024-09-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001437283 us-gaap:RetainedEarningsMember 2024-09-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001437283 us-gaap:CommonStockMember 2022-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001437283 us-gaap:RetainedEarningsMember 2022-12-31 0001437283 us-gaap:NoncontrollingInterestMember 2022-12-31 0001437283 2022-12-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001437283 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001437283 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001437283 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001437283 2023-01-01 2023-03-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001437283 us-gaap:CommonStockMember 2023-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001437283 us-gaap:RetainedEarningsMember 2023-03-31 0001437283 us-gaap:NoncontrollingInterestMember 2023-03-31 0001437283 2023-03-31 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001437283 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001437283 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001437283 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001437283 2023-04-01 2023-06-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001437283 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001437283 us-gaap:CommonStockMember 2023-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001437283 us-gaap:RetainedEarningsMember 2023-06-30 0001437283 us-gaap:NoncontrollingInterestMember 2023-06-30 0001437283 2023-06-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001437283 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001437283 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001437283 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001437283 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001437283 us-gaap:CommonStockMember 2023-09-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001437283 us-gaap:RetainedEarningsMember 2023-09-30 0001437283 us-gaap:NoncontrollingInterestMember 2023-09-30 0001437283 2023-09-30 0001437283 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001437283 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-09-30 0001437283 us-gaap:SubsequentEventMember 2024-11-14 0001437283 srt:ChiefExecutiveOfficerMember 2024-09-30 0001437283 srt:ChiefExecutiveOfficerMember 2023-12-31 0001437283 srt:ChiefFinancialOfficerMember 2024-09-30 0001437283 srt:ChiefFinancialOfficerMember 2023-12-31 0001437283 us-gaap:LoansPayableMember 2024-09-30 0001437283 us-gaap:LoansPayableMember 2023-12-31 0001437283 us-gaap:LoansPayableMember 2024-07-01 2024-09-30 0001437283 us-gaap:LoansPayableMember 2024-01-01 2024-09-30 0001437283 us-gaap:LoansPayableMember 2023-07-01 2023-09-30 0001437283 us-gaap:LoansPayableMember 2023-01-01 2023-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember rpmt:PurchaseAgreementMember 2015-03-06 0001437283 rpmt:SecuredConvertiblePromissoryNotesMember 2015-03-06 2015-03-06 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2015-05-11 2015-05-11 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember rpmt:PurchaseAgreementMember 2024-01-01 2024-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember us-gaap:SeriesBPreferredStockMember 2024-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2024-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2023-12-31 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001437283 us-gaap:NotesPayableOtherPayablesMember 2024-07-01 2024-09-30 0001437283 us-gaap:NotesPayableOtherPayablesMember 2024-01-01 2024-09-30 0001437283 us-gaap:NotesPayableOtherPayablesMember 2023-07-01 2023-09-30 0001437283 us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-09-30 0001437283 rpmt:TenPercentageSecuredConvertibleNotesPayableMember us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-09-30 0001437283 rpmt:NotesPayableStockholdersMember 2024-01-01 2024-09-30 0001437283 rpmt:NotesPayableStockholdersMember 2024-09-30 0001437283 rpmt:NotesPayableStockholdersMember 2023-12-31 0001437283 rpmt:NotesPayableStockholdersMember 2023-01-01 2023-12-31 0001437283 rpmt:NotesPayableStockholdersMember 2024-07-01 2024-09-30 0001437283 rpmt:NotesPayableStockholdersMember 2023-07-01 2023-09-30 0001437283 rpmt:NotesPayableStockholdersMember 2023-01-01 2023-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2016-08-26 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember us-gaap:SeriesCPreferredStockMember 2024-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2024-01-01 2024-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2024-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2023-12-31 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2023-01-01 2023-12-31 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2024-07-01 2024-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2023-07-01 2023-09-30 0001437283 rpmt:FourPercentSecuredConvertibleDebtNoteMember 2023-01-01 2023-09-30 0001437283 2024-01-01 2024-01-01 0001437283 2024-09-30 2024-09-30 0001437283 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-09-30 0001437283 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-09-30 0001437283 us-gaap:SeriesCPreferredStockMember 2016-08-31 0001437283 srt:MinimumMember us-gaap:SeriesCPreferredStockMember 2021-08-23 0001437283 srt:MaximumMember us-gaap:SeriesCPreferredStockMember 2021-08-23 0001437283 us-gaap:SeriesCPreferredStockMember 2024-01-01 2024-09-30 0001437283 rpmt:ConsultantMember 2024-09-30 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-01-02 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-01-01 2024-03-31 0001437283 rpmt:OptionAmendmentsAndAdjustmentsMember 2024-01-02 2024-01-02 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-03-29 0001437283 rpmt:OptionAmendmentsMember 2024-01-01 2024-03-31 0001437283 rpmt:OptionAmendmentsAndAdjustmentsMember 2024-03-29 2024-03-29 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-06-10 0001437283 srt:MaximumMember srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-06-10 0001437283 srt:MinimumMember srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-06-10 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-04-01 2024-06-30 0001437283 rpmt:OptionAmendmentsAndAdjustmentsMember 2024-06-10 2024-06-10 0001437283 srt:BoardOfDirectorsChairmanMember rpmt:OptionAmendmentsMember 2024-09-23 0001437283 srt:MaximumMember srt:BoardOfDirectorsChairmanMember 2024-09-23 0001437283 srt:MinimumMember srt:BoardOfDirectorsChairmanMember 2024-09-23 0001437283 rpmt:OptionAmendmentsAndAdjustmentsMember 2024-09-23 2024-09-23 0001437283 rpmt:EquityIncentivePlan2008Member 2024-09-30 0001437283 us-gaap:RestrictedStockUnitsRSUMember rpmt:EquityIncentivePlan2013Member 2024-09-30 0001437283 us-gaap:StockOptionMember 2024-09-30 0001437283 us-gaap:CommonStockMember 2024-09-30 0001437283 us-gaap:StockOptionMember rpmt:RegosMember 2024-01-01 2024-09-30 0001437283 rpmt:RegosMember 2023-12-31 0001437283 rpmt:RegosMember 2023-12-31 2023-12-31 0001437283 rpmt:RegosMember 2024-01-01 2024-09-30 0001437283 rpmt:RegosMember 2024-09-30 0001437283 srt:ChiefExecutiveOfficerMember 2024-03-01 0001437283 srt:ChiefExecutiveOfficerMember 2024-03-01 2024-03-01 0001437283 us-gaap:PrivatePlacementMember 2024-05-16 2024-05-16 0001437283 srt:ChiefExecutiveOfficerMember 2024-05-16 0001437283 srt:BoardOfDirectorsChairmanMember 2024-05-16 0001437283 srt:ChiefFinancialOfficerMember 2024-05-16 0001437283 us-gaap:CommonStockMember 2024-05-31 2024-05-31 0001437283 rpmt:LOCAgreementMember 2023-03-13 0001437283 rpmt:LOCAgreementMember 2024-01-01 2024-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

I, Peter S. Pelullo, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Rego Payment Architectures, Inc. (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: November 14, 2024 By: /s/ Peter S. Pelullo
    Peter S. Pelullo
    Chief Executive Officer

 

 

 

 

 

 

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

I, Joseph R. Toczydlowski, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Rego Payment Architectures, Inc. (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: November 14, 2024 By: /s/ Joseph R. Toczydlowski
    Joseph R. Toczydlowski
    Chief Financial Officer

 

 

 

 

 

 

 

Exhibit 32.1

 

Certification Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

In connection with this Quarterly Report of Rego Payment Architectures, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Peter S. Pelullo, Chief Executive Officer (Principal Executive Officer) of the Registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1) This Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

Date:  November 14, 2024 By: /s/ Peter S. Pelullo
    Peter S. Pelullo
    Chief Executive Officer

 

 

 

 

 

 

 

Exhibit 32.2

 

Certification Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

In connection with this Quarterly Report of Rego Payment Architectures, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph R. Toczydlowski, Chief Financial Officer (Principal Financial Officer) of the Registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1) This Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

Date: November 14, 2024 By: /s/ Joseph R. Toczydlowski
    Joseph R. Toczydlowski
    Chief Financial Officer

 

 

 

 

 

 

v3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Nov. 14, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Information [Line Items]    
Entity Registrant Name REGO PAYMENT ARCHITECTURES, INC.  
Entity Central Index Key 0001437283  
Entity File Number 0-53944  
Entity Tax Identification Number 35-2327649  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 325 Sentry Parkway  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Blue Bell  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19422  
Entity Phone Fax Numbers [Line Items]    
City Area Code (267)  
Local Phone Number 465-7530  
Entity Listings [Line Items]    
Title of 12(b) Security None  
No Trading Symbol Flag true  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   136,148,105
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 4,475,158 $ 6,256,634
Prepaid expenses 50,000 18,322
Deposits 341 341
TOTAL CURRENT ASSETS 4,525,499 6,275,297
OTHER ASSETS    
Patents and trademarks, net of accumulated amortization of $359,698 and $330,179 296,749 325,150
Total other assets 296,749 325,150
TOTAL ASSETS 4,822,248 6,600,447
CURRENT LIABILITIES    
Accounts payable and accrued expenses 8,216,009 7,785,443
Loans payable 42,600 42,600
Preferred stock dividend liability 13,268,823 11,267,790
TOTAL CURRENT LIABILITIES 40,155,131 37,990,499
Notes payable - stockholders 595,000 595,000
CONTINGENCIES
STOCKHOLDERS' DEFICIT    
Common stock, $ .0001 par value; 230,000,000 shares authorized; 136,148,105 shares issued and outstanding at September 30, 2024 and 135,848,105 shares issued and outstanding at December 31, 2023 13,615 13,585
Additional paid in capital 109,874,596 104,707,296
Accumulated deficit (145,221,133) (136,110,967)
STOCKHOLDERS' DEFICIT (35,332,883) (31,390,052)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 4,822,248 6,600,447
Related Parties    
CURRENT LIABILITIES    
Accounts payable and accrued expenses - related parties 15,212 2,059
10% Secured Convertible Notes Payable    
CURRENT LIABILITIES    
Secured convertible notes payable - stockholders 3,036,237 3,316,357
4% Secured Convertible Notes Payable    
CURRENT LIABILITIES    
Secured convertible notes payable - stockholders 14,981,250 14,981,250
Series A Preferred Stock    
STOCKHOLDERS' DEFICIT    
Preferred Stock 10 10
Series B Preferred Stock    
STOCKHOLDERS' DEFICIT    
Preferred Stock 29 24
Series C Preferred Stock    
STOCKHOLDERS' DEFICIT    
Preferred Stock
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Patents and trademarks, net of accumulated amortization (in Dollars) $ 359,698 $ 330,179
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 2,000,000 2,000,000
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 230,000,000 230,000,000
Common stock, shares issued 136,148,105 135,848,105
Common stock, shares outstanding 136,148,105 135,848,105
Series A Preferred Stock    
Preferred stock, shares authorized 195,500 195,500
Preferred stock, shares issued 98,350 98,350
Preferred stock, shares outstanding 98,350 98,350
Series B Preferred Stock    
Preferred stock, shares authorized 347,222 347,222
Preferred stock, shares issued 281,169 234,403
Preferred stock, shares outstanding 281,169 234,403
Series C Preferred Stock    
Preferred stock, shares authorized 300,000 300,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
v3.24.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
NET REVENUE
OPERATING EXPENSES        
Transaction expense 86,955 56,581 287,288 171,543
Sales and marketing 116,605 468,115 526,065 1,475,458
Product development 912,706 758,614 2,592,996 2,051,020
General and administrative 810,411 905,699 2,961,321 9,534,184
Total operating expenses 1,926,677 2,189,009 6,367,670 13,232,205
NET OPERATING LOSS (1,926,677) (2,189,009) (6,367,670) (13,232,205)
OTHER EXPENSE        
Interest expense (247,310) (254,313) (741,461) (762,235)
Total Other Interest expense (247,310) (254,313) (741,461) (762,235)
NET LOSS (2,173,987) (2,443,322) (7,109,131) (13,994,440)
LESS: Accrued preferred dividends (704,599) (653,656) (2,001,033) (1,565,584)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,878,586) $ (3,096,978) $ (9,110,164) $ (15,560,024)
BASIC NET LOSS PER COMMON SHARE (in Dollars per share) $ (0.02) $ (0.02) $ (0.07) $ (0.12)
DILUTED NET LOSS PER COMMON SHARE (in Dollars per share) $ (0.02) $ (0.02) $ (0.07) $ (0.12)
BASIC WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (in Shares) 136,148,105 135,532,720 135,998,654 130,193,896
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (in Shares) 136,148,105 135,532,720 135,998,654 130,193,896
v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)
Preferred Stock
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interests
Total
Balance at Dec. 31, 2022 $ 10 $ 17 $ 12,416 $ 83,255,319 $ (117,157,414) $ (97,704) $ (33,987,356)
Balance (in Shares) at Dec. 31, 2022 100,350 162,485 124,160,885        
Sale of Series B Preferred Stock   759,999 759,999
Sale of Series B Preferred Stock (in Shares) 8,444        
Issuance of common stock to board members and employees $ 720 8,278,430 8,279,150
Issuance of common stock to board members and employees (in Shares)       7,200,000        
Conversion of Series A Preferred Stock into common stock $ 22 (22)
Conversion of Series A Preferred Stock into common stock (in Shares) (2,000)     222,220        
Exercise of options $ 8 79,592 79,600
Exercise of options (in Shares)       80,000        
Fair value of options for services 504,862 504,862
Accrued preferred dividends (261,966) (4,898) (266,864)
Net loss (5,408,901) (5,408,901)
Balance at Mar. 31, 2023 $ 10 $ 17 $ 13,166 92,878,180 (122,828,281) (102,602) (30,039,510)
Balance (in Shares) at Mar. 31, 2023 98,350 170,929 131,663,105        
Balance at Dec. 31, 2022 $ 10 $ 17 $ 12,416 83,255,319 (117,157,414) (97,704) (33,987,356)
Balance (in Shares) at Dec. 31, 2022 100,350 162,485 124,160,885        
Net loss               (13,994,440)
Balance at Sep. 30, 2023 $ 10 $ 24   $ 13,565 103,571,942 (132,702,539) (112,602) (29,229,600)
Balance (in Shares) at Sep. 30, 2023 98,350 232,737   135,648,105        
Balance at Mar. 31, 2023 $ 10 $ 17 $ 13,166 92,878,180 (122,828,281) (102,602) (30,039,510)
Balance (in Shares) at Mar. 31, 2023 98,350 170,929 131,663,105        
Sale of Series B Preferred Stock $ 6 5,092,494 5,092,500
Sale of Series B Preferred Stock (in Shares)   56,585            
Issuance of common stock to board members and employees $ 138 1,662,613 1,662,751
Issuance of common stock to board members and employees (in Shares)       1,375,000        
Issuance of common stock to consultants $ 25 312,475 312,500
Issuance of common stock to consultants (in Shares)       250,000        
Exercise of options $ 196 546,854 547,050
Exercise of options (in Shares)       1,960,000        
Fair value of options for services 1,907,746 1,907,746
Accrued preferred dividends (640,063) (5,000) (645,063)
Net loss (6,142,217) (6,142,217)
Balance at Jun. 30, 2023 $ 10 $ 23 $ 13,525 102,400,362 (129,610,561) (107,602) (27,304,243)
Balance (in Shares) at Jun. 30, 2023 98,350 227,514   135,248,105        
Sale of Series B Preferred Stock   $ 1     469,899     469,900
Sale of Series B Preferred Stock (in Shares)   5,223            
Issuance of common stock to board members and employees       $ 20 247,980     248,000
Issuance of common stock to board members and employees (in Shares)       200,000        
Exercise of options       $ 20 179,980     180,000
Exercise of options (in Shares)       200,000        
Fair value of options for services         273,721     273,721
Accrued preferred dividends           (648,656) (5,000) (653,656)
Net loss           (2,443,322)   (2,443,322)
Balance at Sep. 30, 2023 $ 10 $ 24   $ 13,565 103,571,942 (132,702,539) (112,602) (29,229,600)
Balance (in Shares) at Sep. 30, 2023 98,350 232,737   135,648,105        
Balance at Dec. 31, 2023 $ 10 $ 24 $ 13,585 104,707,296 (136,110,967) (31,390,052)
Balance (in Shares) at Dec. 31, 2023 98,350 234,403 135,848,105        
Conversion of 10% secured convertible notes into Series B Preferred Stock $ 1 485,893 485,894
Conversion of 10% secured convertible notes into Series B Preferred Stock (in Shares)   5,399            
Fair value of options for services 114,522 114,522
Accrued preferred dividends (630,140) (630,140)
Net loss (2,291,463) (2,291,463)
Balance at Mar. 31, 2024 $ 10 $ 25 $ 13,585 105,307,711 (139,032,570) (33,711,239)
Balance (in Shares) at Mar. 31, 2024 98,350 239,802   135,848,105        
Balance at Dec. 31, 2023 $ 10 $ 24 $ 13,585 104,707,296 (136,110,967) (31,390,052)
Balance (in Shares) at Dec. 31, 2023 98,350 234,403 135,848,105        
Net loss               (7,109,131)
Balance at Sep. 30, 2024 $ 10 $ 29   $ 13,615 109,874,596 (145,221,133)   (35,332,883)
Balance (in Shares) at Sep. 30, 2024 98,350 281,169   136,148,105        
Balance at Mar. 31, 2024 $ 10 $ 25 $ 13,585 105,307,711 (139,032,570) (33,711,239)
Balance (in Shares) at Mar. 31, 2024 98,350 239,802   135,848,105        
Sale of Series B Preferred Stock $ 4 3,723,016 3,723,020
Sale of Series B Preferred Stock (in Shares)   41,367            
Issuance of common stock to board members and employees $ 30 307,470 307,500
Issuance of common stock to board members and employees (in Shares)       300,000        
Fair value of options for services 395,063 395,063
Accrued preferred dividends (666,296) (666,296)
Net loss (2,643,681) (2,643,681)
Balance at Jun. 30, 2024 $ 10 $ 29 $ 13,615 109,733,260 (142,342,547) (32,595,633)
Balance (in Shares) at Jun. 30, 2024 98,350 281,169   136,148,105        
Fair value of options for services         141,336     141,336
Accrued preferred dividends           (704,599)   (704,599)
Net loss           (2,173,987)   (2,173,987)
Balance at Sep. 30, 2024 $ 10 $ 29   $ 13,615 $ 109,874,596 $ (145,221,133)   $ (35,332,883)
Balance (in Shares) at Sep. 30, 2024 98,350 281,169   136,148,105        
v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) (Parentheticals)
3 Months Ended
Mar. 31, 2024
Statement of Stockholders' Equity [Abstract]  
Conversion of secured convertible notes 10.00%
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (7,109,131) $ (13,994,440)
Adjustments to reconcile net loss to net cash used in operating activities:    
Fair value of common stock issued in exchange for services 307,500 10,502,401
Fair value of options issued in exchange for services 650,921 2,686,330
Depreciation and amortization 29,519 29,090
Decrease (increase) in assets    
Prepaid expenses (31,678) (653)
Increase (decrease) in liabilities    
Accounts payable and accrued expenses 636,337 667,526
Accounts payable and accrued expenses - related parties 13,153 9,744
Common stock to be issued (5,350,000)
Net cash used in operating activities (5,503,379) (5,450,002)
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment in patents (1,118) (11,215)
Net cash used in investing activities (1,118) (11,215)
CASH FLOWS FROM FINANCING ACTIVITIES    
Exercise of options 806,650
Proceeds from sale of Series B Preferred Stock 3,723,021 6,322,399
Net cash provided by financing activities 3,723,021 7,129,049
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (1,781,476) 1,667,832
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 6,256,634 6,005,667
CASH AND CASH EQUIVALENTS - END OF PERIOD 4,475,158 7,673,499
Interest
Income taxes
Cash paid during period for:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Accrued preferred dividends 2,001,033 1,565,583
Conversion of Series A Preferred Stock to common stock 22
Conversion of 10% secured convertible note payable and accrued interest into 5,399 shares of Series B Preferred Stock $ 485,893
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals)
9 Months Ended
Sep. 30, 2024
shares
Convertible note payable  
Interest rate on secured convertible note payable 0.10
Series B preferred stock  
Number of preferred shares authorized to receive accrued interest 5,399
v3.24.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of the Business

 

REGO Payment Architectures, Inc. (“REGO”) was incorporated in the state of Delaware on February 11, 2008.

 

REGO Payment Architectures, Inc. and its subsidiaries (collectively, except where the context requires, the “Company”) is a provider of consumer software that delivers a mobile payment platform —Mazoola® - a family focused mobile banking solution. Headquartered in Blue Bell, Pennsylvania, the Company maintains a portfolio of trade secrets and four US patent awards. REGO offers an all-digital financial payments platform to enable minors, particularly under 13 years old, to purchase goods and services, complete chores and learn in a secure online environment guided by parental permission, oversight, and control, while remaining Children’s Online Privacy Protection Act (“COPPA”) and General Data Protection Regulation (“GDPR”) compliant.

 

Management believes that building on its COPPA advantage that the future of REGO Payment Architectures, Inc. will be based on the foundational architecture of its technology platform (the “Platform”) that will allow its use across multiple financial markets where secure controlled payments are needed. The Company intends to license in each alternative field of use the ability for its partners, distributors and/or value-added resellers to private label each of the alternative markets. These partners would deploy, customize and support each implementation under their own label, but with acknowledgement of the Company’s proprietary intellectual assets as the base technology. Management believes this approach will enable the Company to reduce expenses while broadening its reach.

 

Revenues generated from the Platform will come from multiple sources depending on the level of service and facilities requested by the parent. The Company’s model contemplates levels of subscription revenue paid monthly, service fees, transaction fees and revenue sharing and licensing with banking and distribution partners.

 

The Company’s principal office is located in Blue Bell, Pennsylvania.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the financial statements and have been prepared on a consistent basis using the accounting policies described in the summary of accounting policies included in the Company’s 2023 Annual Report on Form 10-K (the “Form 10-K”). All significant intercompany transactions and balances have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed, or omitted pursuant to such rules and regulations, although the Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

 

The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional financing to operationalize the Company’s current technology before another company develops or markets similar technology to compete with the Company.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

As of September 30, 2024, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.

v3.24.3
Management Plans
9 Months Ended
Sep. 30, 2024
Management Plans [Abstract]  
MANAGEMENT PLANS

NOTE 2 – MANAGEMENT PLANS

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant losses and experienced negative cash flow from operations since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Since inception, the Company has focused on developing and implementing its business plan. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. The Company currently needs to generate revenue in order to sustain its operations. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

 

The Company’s current monetization model is to derive revenues from levels of service fees, transaction fees and in some cases revenue sharing with banking and distribution partners. As these bases of revenues grow, the Company expects to generate additional revenue to support operations.

 

As of November 14, 2024, the Company has a cash position of approximately $3.9 million. Based upon the current cash position and the Company’s planned expense run rate, management believes the Company has funds currently to finance its operations on a limited basis through April 2025.

v3.24.3
Accounts Payable and Accrued Expenses - Related Parties
9 Months Ended
Sep. 30, 2024
Accounts Payable and Accrued Expenses - Related Parties [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES - RELATED PARTIES

NOTE 3 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES - RELATED PARTIES

 

As of September 30, 2024 and December 31, 2023, the Company owed the Chief Executive Officer, who is also a more than 5% beneficial owner, a total of $10,096 and $1,328 in unpaid salary.

 

As of September 30, 2024 and December 31, 2023, the Company owed the Chief Financial Officer $5,116 and $731 in unpaid salary.

v3.24.3
Loans Payable
9 Months Ended
Sep. 30, 2024
Loans Payable [Abstract]  
LOANS PAYABLE

NOTE 4 – LOANS PAYABLE

 

Loans payable as of September 30, 2024 and December 31, 2023 were $42,600. Interest accrued on the loans at 6% and 10% was $11,955 and $9,731 as of September 30, 2024 and December 31, 2023. Interest expense related to these loans payable was $747 and $2,224 for the three and nine months ended September 30, 2024 and $747 and $2,216 for the three and nine months ended September 30, 2023.

v3.24.3
10% Secured Convertible Notes Payable - Stockholders
9 Months Ended
Sep. 30, 2024
10% Secured Convertible Notes Payable - Stockholders [Abstract]  
10% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

NOTE 5 – 10% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

 

On March 6, 2015, the Company, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”), issued $2,000,000 aggregate principal amount of its 10% Secured Convertible Promissory Notes due March 5, 2016 (the “Notes”) to certain stockholders. On May 11, 2015, the Company issued an additional $940,000 of Notes to stockholders. The maturity dates of the Notes have been extended most recently to December 31, 2024 with consent of the Note holders.

 

The Notes are convertible by the holders, at any time, into shares of the Company’s Series B Preferred Stock at a conversion price of $90.00 per share, subject to adjustment for stock splits, stock dividends and similar transactions with respect to the Series B Preferred Stock only. Each share of Series B Preferred Stock is currently convertible into 100 shares of the Company’s common stock at a current conversion price of $0.90 per share, subject to anti-dilution adjustment as described in the Certificate of Designation of the Series B Preferred Stock. In addition, pursuant to the terms of a Security Agreement entered into on May 11, 2015 by and among the Company, the Note holders and a collateral agent acting on behalf of the Note holders (the “Security Agreement”), the Notes are secured by a lien against substantially all of the Company’s business assets. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series B Preferred Stock upon a conversion of the Notes.

 

The Notes are recorded as a current liability as of September 30, 2024 and December 31, 2023 in the amount of $3,036,237 and $3,316,357. Interest accrued on the Notes was $2,864,818 and $2,842,873 as of September 30, 2024 and December 31, 2023. Interest expense related to these Notes payable was $75,906 and $227,718 for the three and nine months ended September 30, 2024 and $82,909 and $248,727 for the three months and nine months ended September 30, 2023.

 

During the nine months ended September 30, 2024, a 10% Secured Convertible Noteholder converted $280,120 of principal plus $205,773 of accrued interest into 5,399 shares of Series B Preferred Stock.

v3.24.3
Notes Payable – Stockholders
9 Months Ended
Sep. 30, 2024
Notes Payable – Stockholders [Abstract]  
NOTES PAYABLE – STOCKHOLDERS

NOTE 6 – NOTES PAYABLE – STOCKHOLDERS

 

These notes payable have no formal repayment terms and $370,000 of the notes bear interest at 10% per annum and the remaining $225,000 of the notes bear interest at 20% per annum.

 

These notes payable are recorded as a current liability as of September 30, 2024 and December 31, 2023 in the amount of $595,000. Interest accrued on the notes, as of September 30, 2024 and December 31, 2023 was $424,593 and $361,026. Interest expense, including accretion of discounts, and warrants issued related to these notes payable was $22,330 and $63,567 for the three and nine months ended September 30, 2024 and $20,845 and $61,855 for the three and nine months ended September 30, 2023.

v3.24.3
4% Secured Convertible Notes Payable - Stockholders
9 Months Ended
Sep. 30, 2024
10% Secured Convertible Notes Payable - Stockholders [Abstract]  
4% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

NOTE 7 – 4% SECURED CONVERTIBLE NOTES PAYABLE - STOCKHOLDERS

 

On August 26, 2016, the Company, pursuant to a Securities Purchase Agreement, issued $600,000 aggregate principal amount of its 4.0% Secured Convertible Promissory Notes due June 30, 2019 (the “New Secured Notes”) to certain accredited investors (“investors”). The Company issued additional New Secured Notes during the years 2016 through 2022.

 

The New Secured Notes are convertible by the holders, at any time, into shares of the Company’s authorized Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”) at a conversion price of $90.00 per share, subject to adjustment for stock splits, stock dividends and similar transactions with respect to the Series C Preferred Stock only. Each share of Series C Preferred Stock is currently convertible into 100 shares of the Company’s common stock at a current conversion price of $0.90 per share, subject to full ratchet anti-dilution adjustment for one year and weighted average anti-dilution adjustment thereafter, as described in the Certificate of Designation of the Series C Preferred Stock. Upon a liquidation event, the Company shall first pay to the holders of the Series C Preferred Stock, on a pari passu basis with the holders of the Company’s outstanding Series A Preferred Stock and Series B Preferred Stock, an amount per share equal to 700% of the conversion price (i.e., $630.00 per share of Series C Preferred Stock), plus all accrued and unpaid dividends on each share of Series C Preferred Stock (the “Series C Preference Amount”). The Series C Preference Amount shall be paid prior and in preference to payment of any amounts to the Common Stock. After the payment of all preferential amounts required to be paid to the holders of shares of Series C Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and any additional senior preferred stock, the Series C Preferred Stock participates in further distributions subject to an aggregate cap of seven and one-half times (7.5x) the original issue price thereof, plus all accrued and unpaid dividends.

 

The maturity dates of the New Secured Notes were extended by the investors most recently to December 31, 2024.

 

The New Secured Notes are recorded as a current liability in the amount of $14,981,250 as of September 30, 2024 and December 31, 2023. Interest accrued on the New Secured Notes was $3,199,136 as of September 30, 2024 and $2,749,699, as of December 31, 2023. Interest expense, including the accretion of discounts related to these New Secured Notes was $149,813 and $449,437 for the three and nine months ended September 30, 2024 and September 30, 2023.

v3.24.3
Income Taxes
9 Months Ended
Sep. 30, 2024
Income Taxes [Abstract]  
INCOME TAXES

NOTE 8 – INCOME TAXES

 

Income tax expense was $0 for the three and nine months ended September 30, 2024 and 2023.

 

As of January 1, 2024, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2024 related to unrecognized tax benefits. There has been no change in unrecognized tax benefits during the three and nine months ended September 30, 2024, and there was no accrual for uncertain tax positions as of September 30, 2024. Tax years from 2020 through 2023 remain subject to examination by major tax jurisdictions.

 

There is no income tax benefit for the losses for the three and nine months ended September 30, 2024 and 2023, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.

v3.24.3
Convertible Preferred Stock
9 Months Ended
Sep. 30, 2024
Convertible Preferred Stock [Abstract]  
CONVERTIBLE PREFERRED STOCK

NOTE 9 – CONVERTIBLE PREFERRED STOCK

 

Rego Payment Architectures, Inc. Series A Preferred Stock

 

The Series A Preferred Stock has a preference in liquidation equal to two times its original issue price, or $19,670,000, to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 2.5 times its original issue price. The Series A Preferred stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series A Preferred Stock can be converted. The Series A Preferred Stock also contains customary approval rights with respect to certain matters. The Series A Preferred Stock accrues dividends at the rate of 8% per annum or $8.00 per Series A Preferred Share.

 

The conversion price of Series A Preferred Stock is currently $0.90 per share. The Series A Preferred Stock is subject to mandatory conversion if certain registration or related requirements are satisfied and the average closing price of the Rego’s common stock exceeds 2.5 times the conversion price over a period of twenty consecutive trading days.

 

Rego Payment Architectures, Inc. Series B Preferred Stock

 

The Series B Preferred Stock is pari passu with the Series A Preferred Stock and has a preference in liquidation equal to two times its original issue price, or $50,610,420 as of September 30, 2024, to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 2.5 times its original issue price. The Series B Preferred stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series B Preferred Stock can be converted. The Series B Preferred Stock also contains customary approval rights with respect to certain matters. The Series B Preferred Stock accrues dividends at the rate of 8% per annum.

 

The conversion price of the Series B Preferred Stock is currently $0.90 per share. The Series B Preferred Stock is subject to mandatory conversion if certain registration or related requirements are satisfied and the average closing price of the Company’s common stock exceeds 2.5 times the conversion price over a period of twenty consecutive trading days.

 

During the nine months ended September 30, 2024 and 2023, the Company sold 41,367 and 70,252 shares of the Company’s Series B Preferred Stock in private placements to accredited investors and received proceeds of $3,723,021 and $6,322,400.

 

Rego Payment Architectures, Inc. Series C Preferred Stock

 

In August 2016, Rego authorized 150,000 shares of Rego’s Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”). On August 23, 2021, Rego filed with the Delaware Secretary of State an Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series C Cumulative Convertible Preferred Stock, pursuant to which the amount of authorized Series C Preferred Stock was increased from 150,000 shares to 300,000 shares. As of September 30, 2024, none of the Series C Preferred Stock was issued or outstanding. After the date of issuance of Series C Preferred Stock, dividends at the rate of $7.20 per share will begin accruing and will be cumulative. The Series C Preferred Stock is pari passu with the Series A Preferred Stock and Series B Preferred Stock and has a preference in liquidation equal to seven times its original issue price to be paid out of assets available for distribution prior to holders of common stock and thereafter participates with the holders of common stock in any remaining proceeds subject to an aggregate cap of 7.5 times its original issue price. The Series C Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Series C Preferred Stock can be converted. The Series C Preferred Stock also contains customary approval rights with respect to certain matters. There are no outstanding Series C Preferred Shares, therefore the current per annum dividend per share is $0.

 

As of September 30, 2024, the value of the cumulative 8% dividends for all Rego preferred stock was $13,268,823. Such dividends will be paid when and if declared payable by Rego’s board of directors or upon the occurrence of certain liquidation events. In accordance with FASB ASC 260-10-45-11, the Company has recorded these accrued dividends as a current liability.

v3.24.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2024
Stockholders’ Equity [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 10 – STOCKHOLDERS’ EQUITY

 

On February 22, 2024, the Company engaged a merchant bank in a consultative capacity to advise on capital funding and strategic initiatives which include the prospective sale of the Company. The Company will pay a fee equal to 1.5% of the transaction value upon closing. This contingency has not yet been met as of September 30, 2024.

 

Option Amendments and Adjustments

 

On January 2, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 300,000 shares of common stock of the Company at an exercise price of $0.90 per share. These options were scheduled to expire in January 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $66,705 which was expensed during the three months ended March 31, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 62.8%, risk free interest rate of 4.33%, and expected option life of 2.0 years.

 

On March 29, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 125,000 shares of common stock of the Company at an exercise price of $1.31 per share. These options were scheduled to expire in April 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $17,806 which was expensed during the three months ended March 31, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 58.7%, risk free interest rate of 4.59%, and expected option life of 2.0 years.

 

On June 10, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 900,000 shares of common stock of the Company at exercise prices ranging from $0.90 to $1.25 per share. These options were scheduled to expire in the second and third quarter of 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $220,647 which was expensed during the three months ended June 30, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 61.5%, risk free interest rate of 4.87%, and expected option life of 1.5 years.

 

On September 23, 2024, the Board of Directors approved amendments extending the term of certain outstanding options to purchase in the aggregate 652,125 shares of common stock of the Company at exercise prices ranging from $1.22 to $1.70 per share. These options were scheduled to expire in the fourth quarter of 2024 and were each extended to December 31, 2025. The increase in fair value of this term extension was $90,869 which was expensed during the three months ended September 30, 2024. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions for the extended options: no dividend yield, expected volatility of 60.8%, risk free interest rate of 3.91%, and expected option life of 1.25 years.

 

Issuance of Restricted Shares

 

A restricted stock award (“RSA”) is an award of common shares that is subject to certain restrictions during a specified period. Restricted stock awards are independent of option grants and are generally subject to forfeiture if employment terminates prior to the release of the restrictions. The grantee cannot transfer the shares before the restricted shares vest. Shares of nonvested restricted stock have the same voting rights as common stock, are entitled to receive dividends and other distributions thereon and are considered to be currently issued and outstanding. The Company’s restricted stock awards generally vest over a period of one year. The Company expenses the cost of the restricted stock awards, which is determined to be the fair market value of the shares at the date of grant, straight-line over the period during which the restrictions lapse. For these purposes, the fair market value of the restricted stock is determined based on the closing price of the Company’s common stock on the grant date.

v3.24.3
Stock Options and Warrants
9 Months Ended
Sep. 30, 2024
Stock Options and Warrants [Abstract]  
STOCK OPTIONS AND WARRANTS

NOTE 11 – STOCK OPTIONS AND WARRANTS

 

During 2008, the Board of Directors (“Board”) of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the stockholders. Under the 2008 Plan, the Company was authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company. The 2008 Plan was intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). As of September 30, 2024, under the 2008 Plan, options to purchase 200,000 shares of common stock remain outstanding and are unexercised, and no shares are available for grants under the 2008 Plan. The 2008 Plan expired on March 3, 2019.

 

During 2013, the Board adopted the 2013 Equity Incentive Plan (“2013 Plan”), which was approved by stockholders at the 2013 annual meeting of stockholders. Under the 2013 Plan, the Company was authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013 Plan was intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options. As of September 30, 2024, under the 2013 Plan, grants of restricted stock and options to purchase 1,200,000 shares of common stock remain outstanding and are unexercised, and no shares of common stock remained available for grants under the 2013 Plan. The 2013 Plan expired on November 18, 2023.

 

The Company also grants stock options outside the option plans on terms determined by the Board.

 

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

 

Prior to January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company. Beginning January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the historical volatility of the Company’s common stock.

 

The following table presents the weighted-average assumptions used to estimate the fair values of the stock options granted by REGO during the nine months ended September 30, 2024:

 

Risk Free Interest Rate   4.7%
Expected Volatility   60.9%
Expected Life (in years)   2.0 
Dividend Yield   0%
Weighted average estimated fair value of options during the period  $0.37 

 

During the nine months ended September 30, 2024, the Company issued options to purchase 611,150 shares of the Company’s common stock to various consultants and employees. The options were valued at $245,055 fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options. The fair value of options was expensed immediately.

 

The following table summarizes the activities for REGO’s stock options for the nine months ended September 30, 2024:

 

    Options Outstanding 
             Weighted -      
             Average       
             Remaining   Aggregate 
        Weighted-   Contractual   Intrinsic 
   Number of   Average    Term   Value 
   Shares   Exercise Price   (in years)   (in 000's) (1) 
Balance, December 31, 2023   14,320,000   $0.90    1.5   $8,416 
                     
Granted   611,150    1.03    1.7    
-
 
Exercised   
-
    
-
    
-
    
-
 
Expired/Cancelled   (747,500)   0.90    
-
    
-
 
                     
Balance, September 30, 2024   14,183,650   $0.86    1.1   $3,306 
                     
Exercisable at September 30, 2024 and expected to vest thereafter   14,183,650   $0.86    1.1   $3,306 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $1.05 for the Company’s common stock on September 30, 2024.

 

REGO expensed $131,497 and $650,921 for the three and nine months ended September 30, 2024 and $273,721 and $2,686,330 for the three and nine months ended September 30, 2023 with respect to stock options.

 

As of September 30, 2024, there was $0 of unrecognized compensation cost related to outstanding stock options. The difference, if any, between the stock options exercisable at September 30, 2024 and the stock options exercisable and expected to vest relates to management’s estimate of options expected to vest in the future.

v3.24.3
Operating Leases
9 Months Ended
Sep. 30, 2024
Operating Leases [Abstract]  
OPERATING LEASES

NOTE 12 – OPERATING LEASES

 

For the three and nine months ended September 30, 2024 total rent expense under short-term leases amounted to $1,315 and $3,970 and for the three and nine months ended September 30, 2023 total rent under short-term leases amounted to $5,017 and $7,500. The Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases. The Company has no long-term lease obligations as of September 30, 2024.

v3.24.3
Related Party Transactions
9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 13 – RELATED PARTY TRANSACTIONS

 

On March 1, 2024, the Chief Executive Officer and the Chief Financial Officer each received cash bonuses of $30,000 for a total of $60,000 in aggregate.

 

On May 16, 2024 the following performance bonuses were earned pursuant the successful completion of the Series B Preferred financing accomplished via a final $3.5 million private placement: 1) Shares of Common Stock: Chief Executive Officer: 300,000 shares; 2) Cash Compensation: Chairman: $50,000; Chief Executive Officer: $50,000; and Chief Financial Officer: $30,000. For the Common Stock award, the Company recorded share-based compensation expense of $307,500, the fair value of the Common Stock issued, in May 2024.

v3.24.3
Investor Private Line of Credit
9 Months Ended
Sep. 30, 2024
Investor Private Line of Credit [Abstract]  
INVESTOR PRIVATE LINE OF CREDIT

NOTE 14 - INVESTOR PRIVATE LINE OF CREDIT

 

On March 13, 2023, the Company entered into an Investor Private Line of Credit agreement (the “LOC Agreement”) with an existing shareholder of the Company (the “Lender”). Pursuant to this agreement, the Lender may extend unsecured loans to the Company in the amount of up to twenty million dollars ($20,000,000) which may be drawn upon by the Company for a period of one year in order to provide additional capital to facilitate the Company’s operations. Drawings may be made by the Company as long as there has not been any material change in the operations of the Company. Loans under the LOC Agreement bear interest at the rate of 7% per annum. Drawings under the LOC Agreement must be repaid in full:(i) upon the execution and completion of a sale, merger or other transaction of the Company whereby the Company transfers its ownership and/or its assets to a third party within thirty (30) days of the completion of the transaction (a “Change of Control”) or (ii) if a Change of Control does not occur within one year from the date of the LOC Agreement, the Company will repay any amounts outstanding within sixty (60) days.

 

On March 13, 2024, the Company entered into an Amendment to Investor Private Line of Credit (the “Amendment”) with the Lender. The Amendment extended the maturity date of the existing Investor Private Line of Credit Agreement with the Lender by one year, from March 13, 2024 to March 13, 2025.

 

As of September 30, 2024 the outstanding balance on this LOC Agreement is $0.

v3.24.3
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (2,173,987) $ (2,443,322) $ (7,109,131) $ (13,994,440)
v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Nature of the Business

Nature of the Business

REGO Payment Architectures, Inc. (“REGO”) was incorporated in the state of Delaware on February 11, 2008.

REGO Payment Architectures, Inc. and its subsidiaries (collectively, except where the context requires, the “Company”) is a provider of consumer software that delivers a mobile payment platform —Mazoola® - a family focused mobile banking solution. Headquartered in Blue Bell, Pennsylvania, the Company maintains a portfolio of trade secrets and four US patent awards. REGO offers an all-digital financial payments platform to enable minors, particularly under 13 years old, to purchase goods and services, complete chores and learn in a secure online environment guided by parental permission, oversight, and control, while remaining Children’s Online Privacy Protection Act (“COPPA”) and General Data Protection Regulation (“GDPR”) compliant.

Management believes that building on its COPPA advantage that the future of REGO Payment Architectures, Inc. will be based on the foundational architecture of its technology platform (the “Platform”) that will allow its use across multiple financial markets where secure controlled payments are needed. The Company intends to license in each alternative field of use the ability for its partners, distributors and/or value-added resellers to private label each of the alternative markets. These partners would deploy, customize and support each implementation under their own label, but with acknowledgement of the Company’s proprietary intellectual assets as the base technology. Management believes this approach will enable the Company to reduce expenses while broadening its reach.

Revenues generated from the Platform will come from multiple sources depending on the level of service and facilities requested by the parent. The Company’s model contemplates levels of subscription revenue paid monthly, service fees, transaction fees and revenue sharing and licensing with banking and distribution partners.

The Company’s principal office is located in Blue Bell, Pennsylvania.

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the financial statements and have been prepared on a consistent basis using the accounting policies described in the summary of accounting policies included in the Company’s 2023 Annual Report on Form 10-K (the “Form 10-K”). All significant intercompany transactions and balances have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed, or omitted pursuant to such rules and regulations, although the Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional financing to operationalize the Company’s current technology before another company develops or markets similar technology to compete with the Company.

Recently Issued Accounting Pronouncements Not Yet Adopted

Recently Issued Accounting Pronouncements Not Yet Adopted

As of September 30, 2024, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.

v3.24.3
Stock Options and Warrants (Tables)
9 Months Ended
Sep. 30, 2024
Stock Options and Warrants [Abstract]  
Schedule of Weighted-Average Assumptions Used to Estimate the Fair Values of Stock Options Granted The following table presents the weighted-average assumptions used to estimate the fair values of the stock options granted by REGO during the nine months ended September 30, 2024:
Risk Free Interest Rate   4.7%
Expected Volatility   60.9%
Expected Life (in years)   2.0 
Dividend Yield   0%
Weighted average estimated fair value of options during the period  $0.37 
Schedule of Stock Option The following table summarizes the activities for REGO’s stock options for the nine months ended September 30, 2024:
    Options Outstanding 
             Weighted -      
             Average       
             Remaining   Aggregate 
        Weighted-   Contractual   Intrinsic 
   Number of   Average    Term   Value 
   Shares   Exercise Price   (in years)   (in 000's) (1) 
Balance, December 31, 2023   14,320,000   $0.90    1.5   $8,416 
                     
Granted   611,150    1.03    1.7    
-
 
Exercised   
-
    
-
    
-
    
-
 
Expired/Cancelled   (747,500)   0.90    
-
    
-
 
                     
Balance, September 30, 2024   14,183,650   $0.86    1.1   $3,306 
                     
Exercisable at September 30, 2024 and expected to vest thereafter   14,183,650   $0.86    1.1   $3,306 
(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $1.05 for the Company’s common stock on September 30, 2024.
v3.24.3
Management Plans (Details)
$ in Millions
Nov. 14, 2024
USD ($)
Subsequent Event [Member]  
Management Plans [Line Items]  
Cash position $ 3.9
v3.24.3
Accounts Payable and Accrued Expenses - Related Parties (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Chief Executive Officer [Member]    
Accounts Payable and Accrued Expenses – Related Parties [Line Items]    
Beneficial owner, percentage 5.00% 5.00%
Unpaid salary $ 10,096 $ 1,328
Chief Financial Officer [Member]    
Accounts Payable and Accrued Expenses – Related Parties [Line Items]    
Unpaid salary $ 5,116 $ 731
v3.24.3
Loans Payable (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Loans Payable [Line Items]          
Loans payable $ 42,600   $ 42,600   $ 42,600
Loans Payable [Member]          
Loans Payable [Line Items]          
Interest accrued rate 6.00%   6.00%   10.00%
Interest accrued $ 11,955   $ 11,955   $ 9,731
Interest expense loans payable $ 747 $ 747 $ 2,224 $ 2,216  
v3.24.3
10% Secured Convertible Notes Payable - Stockholders (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 11, 2015
Mar. 06, 2015
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Debt Instrument [Line Items]                
Conversion rate       10.00%        
Ten Percentage Secured Convertible Notes Payable [Member]                
Debt Instrument [Line Items]                
Issued principal amount $ 940,000         $ 205,773    
Current liability     $ 3,036,237     3,036,237   $ 3,316,357
Accrued interest           $ 2,864,818   $ 2,842,873
Percentage of secured convertible     10.00%     10.00%    
Principal amount of secured convertible debt     $ 280,120     $ 280,120    
Secured Convertible Promissory Notes [Member]                
Debt Instrument [Line Items]                
Conversion rate   10.00%            
Notes Payable [Member]                
Debt Instrument [Line Items]                
Interest expense     $ 75,906   $ 82,909 $ 227,718 $ 248,727  
Purchase Agreement [Member] | Ten Percentage Secured Convertible Notes Payable [Member]                
Debt Instrument [Line Items]                
Aggregate principal amount   $ 2,000,000            
Debt instrument, maturity date           Dec. 31, 2024    
Series B Preferred Stock [Member]                
Debt Instrument [Line Items]                
Conversion price (in Dollars per share)     $ 0.9     $ 0.9    
Series B Preferred Stock [Member] | Ten Percentage Secured Convertible Notes Payable [Member]                
Debt Instrument [Line Items]                
Conversion price (in Dollars per share)     $ 90     $ 90    
Convertible shares (in Shares)     100     100    
Shares of series B preferred stock (in Shares)           5,399    
v3.24.3
Notes Payable – Stockholders (Details) - Notes Payable - Stockholders [Member] - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Notes Payable - Stockholders [Line Items]          
Repayments of notes payable     $ 370,000    
Interest rate 10.00%   10.00%    
Notes payable remaining $ 225,000   $ 225,000    
Interest rate remaining 20.00%   20.00%    
Notes payable $ 595,000   $ 595,000   $ 595,000
Interest accrued     424,593   $ 361,026
Interest expense $ 22,330 $ 20,845 $ 63,567 $ 61,855  
v3.24.3
4% Secured Convertible Notes Payable - Stockholders (Details) - 4.0% Secured Convertible Note [Member] - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Aug. 26, 2016
Debt Instrument [Line Items]            
Aggregate principal amount           $ 600,000
Convertible promissory notes percentage           4.00%
Maturity date     Dec. 31, 2024      
Current liability amount $ 14,981,250   $ 14,981,250   $ 14,981,250  
Interest accrued     3,199,136   $ 2,749,699  
Interest expense $ 149,813 $ 449,437 $ 149,813 $ 449,437    
Series C Preferred Stock [Member]            
Debt Instrument [Line Items]            
Convertible promissory notes percentage 700.00%   700.00%      
Convertible preferred stock increase (in Dollars per share)     $ 90      
Convertible shares (in Shares)     100      
Convertible preferred stock decrease (in Dollars per share)     $ 0.9      
Conversion price per share (in Dollars per share) $ 630   $ 630      
v3.24.3
Income Taxes (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jan. 01, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Taxes [Abstract]            
Income tax expense     $ 0 $ 0 $ 0 $ 0
Unrecognized tax benefits  
Uncertain tax positions          
v3.24.3
Convertible Preferred Stock (Details) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Aug. 23, 2021
Aug. 31, 2016
Convertible Preferred Stock [Line Items]          
Dividend rate 8.00%        
Authorized shares 2,000,000   2,000,000    
Preferred stock dividend cash (in Dollars) $ 13,268,823        
Series A Preferred Stock [Member]          
Convertible Preferred Stock [Line Items]          
Original issue price (in Dollars) $ 19,670,000        
Dividend rate 8.00%        
Preferred stock, per share (in Dollars per share) $ 8        
Conversion price (in Dollars per share) $ 0.9        
Authorized shares 195,500   195,500    
Preferred stock shares issued 98,350   98,350    
Preferred stock shares outstanding 98,350   98,350    
Series B Preferred Stock [Member]          
Convertible Preferred Stock [Line Items]          
Original issue price (in Dollars) $ 50,610,420        
Dividend rate 8.00%        
Conversion price (in Dollars per share) $ 0.9        
Sale of stock 41,367 70,252      
Received proceeds (in Dollars) $ 3,723,021 $ 6,322,400      
Authorized shares 347,222   347,222    
Preferred stock shares issued 281,169   234,403    
Preferred stock shares outstanding 281,169   234,403    
Series C Preferred Stock [Member]          
Convertible Preferred Stock [Line Items]          
Authorized shares 300,000   300,000   150,000
Preferred stock shares issued 0   0    
Preferred stock shares outstanding 0   0    
Preferred Stock, dividends (in Dollars per share) $ 7.2        
Preferred stock dividend cash (in Dollars) $ 0        
Minimum [Member] | Series C Preferred Stock [Member]          
Convertible Preferred Stock [Line Items]          
Authorized shares       150,000  
Maximum [Member] | Series C Preferred Stock [Member]          
Convertible Preferred Stock [Line Items]          
Authorized shares       300,000  
v3.24.3
Stockholders' Equity (Details) - USD ($)
3 Months Ended
Sep. 23, 2024
Jun. 10, 2024
Mar. 29, 2024
Jan. 02, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Stockholders Stockholders’ Equity [Line Items]              
Increase in fair value (in Dollars)         $ 90,869    
Option Amendments [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Increase in fair value (in Dollars)             $ 17,806
Option Amendments and Adjustments [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Expected volatility 60.80% 61.50% 58.70% 62.80%      
Risk free interest rate 3.91% 4.87% 4.59% 4.33%      
Expected term 1 year 3 months 1 year 6 months 2 years 2 years      
Consultant [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Fee transaction percentage         1.50%    
Board of Directors Chairman [Member] | Option Amendments [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Option to purchase shares (in Shares) 652,125 900,000 125,000 300,000      
Exercise price (in Dollars per share)     $ 1.31 $ 0.9      
Increase in fair value (in Dollars)           $ 220,647 $ 66,705
Board of Directors Chairman [Member] | Maximum [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Exercise price (in Dollars per share) $ 1.22            
Board of Directors Chairman [Member] | Maximum [Member] | Option Amendments [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Exercise price (in Dollars per share)   $ 0.9          
Board of Directors Chairman [Member] | Minimum [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Exercise price (in Dollars per share) $ 1.7            
Board of Directors Chairman [Member] | Minimum [Member] | Option Amendments [Member]              
Stockholders Stockholders’ Equity [Line Items]              
Exercise price (in Dollars per share)   $ 1.25          
v3.24.3
Stock Options and Warrants (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Stock Options and Warrants [Line Items]        
Exercise price fair market value price percentage 100.00%   100.00%  
Outstanding stock, percentage     10.00%  
Issued options to purchase (in Shares)     611,150  
Grant date fair value     $ 245,055  
REGO expense $ 131,497 $ 273,721 $ 650,921 $ 2,686,330
Stock Options [Member]        
Stock Options and Warrants [Line Items]        
Exercise price fair market value price percentage 110.00%   110.00%  
Unrecognized compensation $ 0   $ 0  
Common Stock [Member]        
Stock Options and Warrants [Line Items]        
Exercise price (in Dollars per share) $ 1.05   $ 1.05  
2008 Equity Incentive Plan [Member]        
Stock Options and Warrants [Line Items]        
Shares authorized under plan (in Shares) 25,000,000   25,000,000  
Remain outstanding (in Shares) 200,000   200,000  
2013 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]        
Stock Options and Warrants [Line Items]        
Shares authorized under plan (in Shares) 5,000,000   5,000,000  
Remain outstanding (in Shares) 1,200,000   1,200,000  
v3.24.3
Stock Options and Warrants (Details) - Schedule of Weighted-Average Assumptions Used to Estimate the Fair Values of Stock Options Granted - Stock Option [Member] - REGO [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
Schedule of Weighted-Average Assumptions Used to Estimate the Fair Values of Stock Options Granted [Line Items]  
Risk Free Interest Rate 4.70%
Expected Volatility 60.90%
Expected Life (in years) 2 years
Dividend Yield 0.00%
Weighted average estimated fair value of options during the period (in Dollars per share) $ 0.37
v3.24.3
Stock Options and Warrants (Details) - Schedule of Stock Option - REGO [Member] - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Dec. 31, 2023
Sep. 30, 2024
Schedule of Stock Option [Line Items]    
Number of Shares, Granted   611,150
Weighted Average Exercise Price, Granted   $ 1.03
Weighted Average Remaining Contractual Term, Granted   1 year 8 months 12 days
Aggregate Intrinsic Value, Granted [1]  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Remaining Contractual Term, Exercised  
Aggregate Intrinsic Value, Exercised [1]  
Number of Shares, Expired/Cancelled   (747,500)
Weighted Average Exercise Price, Expired/Cancelled   $ 0.9
Weighted Average Remaining Contractual Term, Expired/Cancelled  
Aggregate Intrinsic Value, Expired/Cancelled [1]  
Number of Shares, Balance 14,320,000 14,183,650
Weighted Average Exercise Price, Balance $ 0.9 $ 0.86
Weighted Average Remaining Contractual Term, Balance 1 year 6 months 1 year 1 month 6 days
Aggregate Intrinsic Value, Balance [1] $ 8,416 $ 3,306
Number of Shares, Exercisable and expected to vest thereafter   14,183,650
Weighted Average Exercise Price, Exercisable and expected to vest thereafter   $ 0.86
Weighted Average Remaining Contractual Term, Exercisable and expected to vest thereafter   1 year 1 month 6 days
Aggregate Intrinsic Value, Exercisable and expected to vest thereafter [1]   $ 3,306
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $1.05 for the Company’s common stock on September 30, 2024.
v3.24.3
Operating Leases (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating Leases [Abstract]        
Total rent expense $ 1,315 $ 5,017 $ 3,970 $ 7,500
Long-term lease obligations    
v3.24.3
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
May 31, 2024
May 16, 2024
Mar. 01, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Related Party Transactions [Line Items]                
Common stock issued (in Shares)       136,148,105   136,148,105   135,848,105
Share based compensation expense       $ 131,497 $ 273,721 $ 650,921 $ 2,686,330  
Chief Executive Officer [Member]                
Related Party Transactions [Line Items]                
Cash bonuses     $ 30,000          
Total aggregate amount     $ 60,000          
Common stock issued (in Shares)   300,000            
Cash compensation   $ 50,000            
Chairman [Member]                
Related Party Transactions [Line Items]                
Cash compensation   50,000            
Chief Financial Officer [Member]                
Related Party Transactions [Line Items]                
Cash compensation   30,000            
Common Stock [Member]                
Related Party Transactions [Line Items]                
Share based compensation expense $ 307,500              
Private Placement [Member]                
Related Party Transactions [Line Items]                
Private placement   $ 3,500,000            
v3.24.3
Investor Private Line of Credit (Details) - LOC Agreement [Member] - USD ($)
9 Months Ended
Sep. 30, 2024
Mar. 13, 2023
Investor Private Line of Credit [Line Items]    
Unsecured loans   $ 20,000,000
Interest rate   7.00%
Outstanding balance $ 0  

Rego Payment Architectures (QB) (USOTC:RPMT)
過去 株価チャート
から 11 2024 まで 12 2024 Rego Payment Architectures (QB)のチャートをもっと見るにはこちらをクリック
Rego Payment Architectures (QB) (USOTC:RPMT)
過去 株価チャート
から 12 2023 まで 12 2024 Rego Payment Architectures (QB)のチャートをもっと見るにはこちらをクリック